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The Scar/WAVE complex drives actin nucleation during cell migration. Interestingly, the same complex is important in forming
membrane ruffles during macropinocytosis, a process mediating nutrient uptake and membrane receptor trafficking.
Mammalian CYRI-B is a recently described negative regulator of the Scar/WAVE complex by RAC1 sequestration, but its other
paralogue, CYRI-A, has not been characterized. Here, we implicate CYRI-A as a key regulator of macropinosome formation and
integrin internalization. We find that CYRI-A is transiently recruited to nascent macropinosomes, dependent on PI3K and RAC1
activity. CYRI-A recruitment precedes RAB5A recruitment but follows sharply after RAC1 and actin signaling, consistent with
it being a local inhibitor of actin polymerization. Depletion of both CYRI-A and -B results in enhanced surface expression of the
α5β1 integrin via reduced internalization. CYRI depletion enhanced migration, invasion, and anchorage-independent growth in
3D. Thus, CYRI-A is a dynamic regulator of macropinocytosis, functioning together with CYRI-B to regulate integrin
trafficking.
Introduction
The actin cytoskeleton is a multifaceted network coordinating
essential cellular processes such as cell migration and endocy-
tosis. The small GTPase RAC1 acts as a regulatory switch at the
heart of this network. By activating the Scar/Wiskott Aldrich
Syndrome Family verprolin homologous protein (WAVE) com-
plex, RAC1 indirectly triggers Arp2/3 complex activation and
thus branched actin polymerization.
RAC1-induced actin polymerization contributes to endocytic
processes (Mooren et al., 2012; Egami et al., 2014; Bloomfield and
Kay, 2016; Ferreira and Boucrot, 2018; Hinze and Boucrot, 2018).
The branched actin network underpins membrane ruffling, a
prerequisite for macropinocytosis, an ancient endocytic path-
way for uptake of external substances, or to counteract cyto-
plasmic hydrostatic pressure to drive membrane curvature and
invagination (Carlsson, 2018). Evidence suggests that a balanced
spatial and temporal regulation of RAC1 and its downstream
cytoskeletal targets at the site of endocytosis is essential. Fol-
lowing RAC1 activation, RAC1 inactivation is required for the
completion of macropinocytosis (Yoshida et al., 2009; Fujii et al.,
2013). Constitutively activating RAC1 by photoactivation led to
unresolved membrane invagination (Fujii et al., 2013). The re-
lated process phagocytosis has been shown to require several
GTPase-activating proteins (GAPs) in the deactivation phase of
RAC1 but only for particles >8 µm (Schlam et al., 2015). How-
ever, the mechanism of RAC1 deactivation in macropinocytosis
remains largely unknown.
Integrins are type I transmembrane proteins important in
cell adhesion and migration, and their endocytic trafficking is
implicated in cancer cell invasion and metastasis (Caswell et al.,
2009; Cooper and Giancotti, 2019). In breast cancer, increased
surface expression of integrin α5 increases the cell contraction
force and invasion (Mierke et al., 2011). In ovarian cancer cells,
integrin α5β1 is transported toward the invasive front by the
Wiskott Aldrich Syndrome Family and Scar homologue complex
to increase invasion in 3D (Zech et al., 2011). Among the traf-
ficking routes, such as clathrin- or caveolin-1–dependent endo-
cytosis (Shi and Sottile, 2008), bulk internalization pathways
such as macropinocytosis and the CLIC-GEEC (Clathrin-inde-
pendent carriers–glycophosphatidylinositol enriched early en-
dosomal compartment) pathway are involved in integrin trafficking
and can affect themigration and invasion behavior of cells (Gu et al.,
2011; Moreno-Layseca et al., 2020 Preprint).
Recently, we identified CYFIP-related RAC1 interacting
(CYRI) proteins as negative regulators of the Scar/WAVE
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complex by RAC1 sequestration (Fort et al., 2018). Actin po-
lymerization by the Scar/WAVE complex also drives the uptake
of cellular pathogens and nutrients by macropinocytosis and
phagocytosis (Veltman et al., 2016; Humphreys et al., 2016).
Indeed, CYRI-B protects against Salmonella infection (Yuki
et al., 2019), regulates T cell activation (Shang et al., 2018),
and potentially acts as a tumor suppressor (Chattaragada et al.,
2018). Mammalian cells possess two paralogs of the CYRI pro-
tein family, named CYRI-A and CYRI-B, which are encoded by
the FAM49A and FAM49B genes, respectively. Nothing is cur-
rently known about the cellular function of CYRI-A and its
relationship with CYRI-B. Through biochemical analyses and
live-cell imaging, we explore the membrane kinetics and sub-
cellular localization of CYRIs, with a strong focus on the un-
characterized CYRI-A. We implicate CYRIs as novel regulators
of macropinocytosis. We then connect the function of both
CYRI-A and -B to the trafficking of integrin α5β1 and their ef-
fects on cell migration, cell spreading, and cancer cell invasion.
We propose that CYRI proteins act as suppressors of the
RAC1–actin signaling axis at macropinocytic structures to en-
sure efficient completion of macropinocytosis.
Results
CYRI-A suppresses lamellipodial spreading and binds active
RAC1
While CYRI-B has been characterized as a RAC1-binding protein
that restricts lamellipodia, the role of CYRI-A is unknown. De-
letion of CYRI-B promotes a broad lamellipodia phenotype with
enrichment of the Scar/WAVE complex at the leading edge (Fort
et al., 2018; Yuki et al., 2019). Our previous study of CYRI-B used
COS-7 cells, which express only very low levels of CYRI-A (Fort
et al., 2018; Fig. S1). To query whether CYRI-A expression could
rescue the cell-spreading phenotype caused by depletion of
CYRI-B, we expressed either a FLAG-tagged GFP (control) or
CYRI-A-FLAG construct (Fig. 1 A) in control or CYRI-B knockout
(KO) COS-7 cells ex3 and ex4.1. CYRI-B KO cells showed en-
hanced lamellipodia spreading (Fort et al., 2018; Fig. 1 A), which
we previously showed was rescued by reexpression of CYRI-B-
FLAG (Fort et al., 2018). Here, we find that CYRI-A rescues
spreading area (Fig. 1 B) and Arp2/3 recruitment (Fig. 1 C).
Western blot showed comparable levels of CYRI-A-FLAG and
GFP-FLAG between cell lines (Fig. 1 D). Expression of untagged
CYRI-A using a bi-cistronic system provided a similar rescue
(Fig. S1 A). This suggests similar functions of CYRI-A and CYRI-B
in controlling lamellipodia formation.
We next queried whether CYRI-A could interact with active
RAC1. Using the I-TASSER protein prediction tool (Zhang, 2008;
Roy et al., 2010; Yang and Zhang, 2015) along with the recently
solved crystal structures of CYRI-B (Yelland et al., 2021; Kaplan
et al., 2020), CYRI-A was predicted to contain an amphipathic
N-terminal α-helix connected via a flexible linker to a bundle of
12 α-helices forming the domain of unknown function (or
DUF1394 domain; Fig. 2 A). Comparing the amino acid sequence
of CYRI-A and CYRI-B showed an 80% sequence identity (Fig. 2
B), including a glycine residue at the second position thought to
be important for myristoylation (Fort et al., 2018) and two
arginine residues at positions 159/160 (for CYRI-A) or 160/161
(for CYRI-B) that are essential for active RAC1 binding (Fort
et al., 2018). Using an in vitro pulldown assay, we showed that
the region of CYRI-A corresponding to the RAC1-binding do-
main (RBD) of CYRI-B (Fort et al., 2018; amino acids 29–319)
robustly and consistently interacted with the constitutively
active RAC1 Q61L (Fig. 2, C and D), but not detectably with WT
or dominant-negative T17N RAC1 (Fig. 2, E and F). To inter-
rogate whether this interaction was direct, we performed
surface plasmon resonance (SPR) using purified recombinant
maltose-binding protein (MBP)–tagged CYRIs immobilized on
an SPR chip, reacted with soluble, untagged constitutively
active RAC1 Q61L. CYRI-A interacts with active RAC1 with a
dissociation constant (Kd) of ∼13 µM, while for CYRI-B, the Kd
is ∼38 µM (Fig. 2 G). Thus CYRI-A is an active RAC1 inter-
acting protein with a higher affinity for active RAC1 than
CYRI-B.
CYRI-A and CYRI-B cooperatively regulate cancer cell
spreading and migration
CYRI-A is expressed at a low to undetectable level in some cell
lines, including HEK293T and COS-7 (Fig. S1 B), so we sought to
find cells that expressed both proteins to further understand
CYRI-A’s role. Using the EMBL-EBI database, we identified
Ewing’s sarcoma cell lines, and particularly A-673 cells, as ex-
pressing both isoforms at relatively comparable RNA levels. We
confirmed the expression of CYRI-A and -B and the specificity
of the antibody in A-673 cells using siRNA (referred to as KD or
knockdown) or CRISPR-Cas9 (referred to as KO; Figs. S1 C and 3
B). Single KO of CYRI-A or CYRI-B in A-673 cells resulted in a
modest but reproducible effect on the cell shape, with a 10%
increase in the number of cells adopting the fast-migrating
C-shape, a previously described phenotype (Yuki et al., 2019;
Fort et al., 2018; Fig. 3, A and C). However, when both CYRI-A
and CYRI-B were simultaneously deleted (referred to as DBKO
for double knockout) we saw a large increase, with 60% of the
cells adopting the C-shape morphology. We observed similar
effects in cells treated with siRNA (Fig. S1, D and E). DBKO A-
673 cells also showed a 30% increase in the spreading area over
control pLKO (plasmid lentiviral knockdown for shRNA ex-
pression) and single KO cells. We measured the migration
speed of both CRISPR or siRNA-treated cells on 2D fibronectin
substrate and in 3D fibroblast cell-derived matrix (CDM;
Cukierman et al., 2001; Fig. 3, D and E; and Fig. S1, F and G). In
all cases, cells lacking both isoforms showed a twofold increase
in their migration speed (0.5 µm/min for DBKO versus 0.2 µm/
min for pLKO on 2D and 0.2 µm/min for DBKO versus 0.1 µm/
min for pLKO in 3D). There were no obvious differences in
motility or morphology between cells lacking just CYRI-A or
CYRI-B. Reintroducing CYRI-A into the DBKO cells reduced the
migration speed to basal level (Fig. 3 F). Measuring the col-
lective migration behavior by scratch-wound assay also showed
a faster wound closure rate in the DBKO cells compared with
either the control pLKO or the single KO (Fig. 3, G and H). This
was not due to enhanced proliferation, as DBKO cells prolifer-
ated more slowly than the other cell lines (DBKO slope, 0.11;
pLKO and single KO slope, 0.15; Fig. 3 I). Overall, we find that
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Figure 1. CYRI-A suppresses cell spreading and leading-edge Arp2/3 complex recruitment. (A) Immunofluorescence images of COS-7 pLKO (control) and
CYRI-B CRISPR KO lines (ex3 or ex4.1) expressing either GFP-FLAG or CYRI-A-FLAG vector and stained for Arp2/3 complex (anti-ArpC2, yellow), FLAG-tag
(magenta), and F-actin (phalloidin, cyan; scale bar = 20 µm). Dotted square denotes zooms (scale bar = 5 µm). (B and C) Cell spread area and Arp2/3 signal at
the leading edge in COS-7 cells expressing either GFP-FLAG (squares) or CYRI-A-FLAG (circles). Data from at least 10 cells per experiment and three inde-
pendent experiments, each colored separately in blue, orange, and green. Statistical analyses using two-tailed unpaired t test. Mean ± SD. (D) Representative
Western blot showing relative expression of GFP-FLAG and CYRI-A-FLAG in COS-7 detected with anti-FLAG antibody. GAPDH as loading control.
Le et al. Journal of Cell Biology 3 of 25
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Figure 2. CYRI-A is similar to CYRI-B in amino acid sequence and RAC1 binding. (A) The molecular structure of CYRI-A as predicted by I-TASSER. The
protein is composed of one N-terminal amphipathic α-helix connected to a domain of unknown function (DUF1394) via a flexible linker. Numbers represent the
amino acid position. (B)Multiple sequence alignment using Clustal Omega of mouse CYRI-A and CYRI-B shows 80% sequence identity. Black, identical residues;
gray, similar residues; red, Glycine (G2) putative myristoylation site; green, two conserved arginine residues (RR) mediating active RAC1 binding. (C) Western
Le et al. Journal of Cell Biology 4 of 25
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CYRI-A and CYRI-B have a compensatory role in regulating cell
shape and migration in A-673 cells.
CYRI-A localizes to macropinocytic structures
Our results, combined with previous observations (Fort et al.,
2018; Yuki et al., 2019) argued that CYRI proteins interacted
directly with RAC1 and opposed its activity at the cell leading
edge. However, almost nothing was known about the cellular
localization or dynamics of CYRI proteins. Fluorescent tagging of
CYRIs has proven difficult, as neither N- nor C-terminal tagging
with GFP preserved their functions (Fort et al., 2018). In an at-
tempt to preserve the N-terminal myristoylation and any role of
the N-terminal α-helix, we inserted GFP just after the 16th
proline residue of CYRI-A (P16-GFP-CYRI-A) or the 17th proline
residue of CYRI-B (P17-GFP-CYRI-B; Fig. S1 H). Both constructs
rescued cell spreading and Arp2/3 complex recruitment in
CYRI-B CRISPR COS-7 cells, suggesting that theywere functional
(Fig. S1, I–K). Transiently expressing P16-GFP-CYRI-A resulted
in a striking localization to vesicular and occasionally tubular
structures (Fig. 4, A–D; and Video 1, clips 1 and 2). Vesicles were
∼1 µm in diameter, while tubule length varied from 2 to 8 µm.
CYRI-A dynamically localized to vesicle structures, with resi-
dent times of ∼50–100 s (Fig. 4, C and G).
Interestingly, CYRI-A was diffusely localized proximal to the
cell leading edge in COS-7, before being recruited to the forming
vesicular structures (Fig. 4 D, arrowheads). In contrast to the
dynamic behavior of CYRI-A, the signal of the P17-GFP-CYRI-B
construct in COS-7 cells on tubules and vesicular structures was
much more stable (Fig. S2 A and Video 2, clip 1). The size of P17-
GFP-CYRI-B–positive vesicles was smaller than that of P16-GFP-
CYRI-A, with an average of 0.5 µm, while tubular structures
were more prominent and could reach up to 20 µm (Fig. S2 B).
These observations not only confirmed the ability of CYRIs to
interact with the cell membrane but also suggested for the first
time a potential difference inmembrane kinetics between CYRI-
A and CYRI-B.
The prominent localization of CYRIs and the size of the ve-
sicular structures suggested a potential role inmacropinocytosis.
Using dual-color live imaging of COS-7 cells, P16-GFP-CYRI-A
demonstrated a transient colocalization with mCherry-RAB5A
(Fig. 4, E–G; and Video 1, clip 3). As the cups/vesicles formed,
P16-GFP-CYRI-A was quickly recruited and remained on the
cups/vesicles for ∼50 s before the RAB5A signal appeared. The
gradual appearance of RAB5A coincided with the gradual loss of
the CYRI-A signal, which took another 50 s (Fig. 4 G). RAB5A
remained on the cups/vesicles as they were being transported
further into the cells. We also verified this observation in
HEK293T cells (Fig. S2, C–E; and Video 2, clip 2). On the other
hand, P17-GFP-CYRI-B remained relatively evenly distributed
on cups/vesicles and tubules over these timescales (Fig. S2, F
and G; and Video 2, clip 3). Due to the relatively large size of
many of the CYRI-A decorated structures, we speculated that
they could be macropinocytic cups or macropinosomes (Canton,
2018; Swanson and Watts, 1995). Using fluorescent dextran
70 kD as a marker for fluid-phase uptake, we found that 75%
of CYRI-A–positive cups/vesicles in COS-7 cells (Fig. 4, H and
I; and Video 1, clip 4) and almost 100% in both HEK293T and
CHL-1 cells contained dextran (Fig. S2, H–M; and Video 2,
clips 4 and 5). The size of these CYRI-A–positive, dextran-positive
structures (0.6–1 µm on average) was similar to Fig. 4, A–D, and
consistent with macropinocytic cups or macropinosomes (Canton,
2018; Swanson and Watts, 1995; Fig. 4 J; Fig. S2, N and O; and
Video 2, clips 6 and 7). We tested the colocalization of CYRI-
A–decorated structures with other endocytosis pathways
including clathrin-mediated endocytosis (CLC15), caveolin-
mediated endocytosis (CAV1), and ARF1-dependent endo-
cytosis (Fig. S3, A–D; and Video 3, clips 1–4) but found no
clear colocalization. Thus, we found that P16-GFP-CYRI-A
was recruited early in bright flashes to nascent macropinosomes,
before RAB5A recruitment, suggesting a role for CYRI-A in
macropinocytosis.
CYRI-A regulates macropinosome formation and forms a
feedback loop with actin
RAC1-driven actin polymerization and membrane ruffling
shapes early macropinocytic cups (Bloomfield and Kay, 2016;
Condon et al., 2018). CYRI proteins are recruited during RAC1-
mediated actin polymerization in lamellipodia (Fort et al.,
2018), locally dampening down ruffles, so we hypothesized
that CYRI-A could affect actin dynamics during the early stages
of macropinocytosis. Cotransfecting COS-7 cells with LifeAct-
RFP and P16-GFP-CYRI-A showed colocalization between actin
and CYRI-A but not with GFP alone (Fig. 5 A and Video 4, clips
1 and 2). Actin accumulation at the forming macropinosome
preceded CYRI-A accumulation (Fig. 5 B and Video 4, clip 3).
Actin dynamics drive the early stages of macropinocytic cup
formation (Yoshida et al., 2009; Mooren et al., 2012; Bloomfield
and Kay, 2016). As the actin signal increased, it was sharply
followed by an increase of the CYRI-A signal (Fig. 5 B, graph,
COS-7 cells), and then both signals decreased, suggesting se-
quential recruitment. HEK293T cells showed similar dynamics
(Fig. 5, C and D; and Video 4, clip 4). On average, the actin signal
persisted on the structures for 36 s before the CYRI-A signal
became detectable. CYRI-A and actin coincided for another 54 s
on average before both decreased, similar to the lifetime of
CYRI-A on these structures before RAB5A appeared (Fig. S2 E).
blots showing GST-Trap pulldown assay of GST or GST-RAC1 (WT or Q61L) with lysate from COS-7 cells expressing GFP (negative control), eCFP-CRIB-PBD
(positive control), or GFP-CYRI-A (29–319; RBD). Probed with anti-GFP and anti-GST. Black arrowhead denotes GFP-CYRIA (29–319) and GST-RAC1 Q61L
interaction. (D)Quantification of C from at least three independent experiments. Signals were normalized to the input. Mean ± SEM. Black arrowhead points to
CYRI-A RBD and active RAC1 interaction. (E)Western blot showing MBP-Trap pulldown assay between MBP-CYRI-A on MBP beads interacting with GST-RAC1
WT, Q61L, or T17N (constitutively inactive). (F) Quantification of E from three independent experiments. Signals were normalized to MBP. Mean ± SD.
Statistical analysis using one-way ANOVA with Tukey’s multiple comparisons. ns, P > 0.05. (G) Steady-state SPR binding curve between purified MBP-tagged
full-length CYRI-A (magenta) or CYRI-B (cyan) and increasing concentrations of untagged full-length RAC1 Q61L with curve fit assuming a 1:1 binding model.
Kd = 1.3 × 10−5 (CYRI-A::RAC1 Q61L) and 3.8 × 10−5 (CYRI-B::RAC1 Q61L). Mean ± SD. Data from at least three independent experiments.
Le et al. Journal of Cell Biology 5 of 25
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Figure 3. CYRI-A and CYRI-B cooperatively regulate cell shape and migration. (A) Immunofluorescence images of control (pLKO), single KO, and DBKO of
CYRIs in A-673 cells. Cells stained for F-actin with phalloidin. Orange arrowheads indicate C-shape cells. Scale bar = 50 µm. (B) Western blots showing the
Le et al. Journal of Cell Biology 6 of 25
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To directly compare the temporal recruitment of CYRIs and
actin during macropinocytosis, we coexpressed LifeAct-RFP
and either GFP alone or P16-GFP-CYRI-A constructs in COS-7
cells depleted of both CYRI-A and CYRI-B using siRNA (DBKD
for double knockdown; Fig. 5, E–G; and Video 5). As expected,
DBKD COS-7 cells were flat, with relatively nondynamic lamelli-
podia. GFP-expressing cells formed significantly fewer mac-
ropinocytic structures (∼4 cups/vesicles/cell) compared with
P16-GFP-CYRI-A rescued cells (∼65 cups/vesicles/cell). Further-
more, macropinocytic structures positive for CYRI-A had a shorter
actin lifetime (∼92 s) compared with those that were negative
(∼212 s). Indeed, DBKD cells accumulated significantly less 70-kD
dextran than controls (Fig. 5, H and I). However, overexpressing
neither P16-GFP-CYRI-A nor mutant RAC1 nonbinding P16-mCh-
CYRI-A-RRDD (Yelland et al., 2021) significantly increased dextran
uptake (Fig. 5, J and K), suggesting a balance of CYRI-A is required.
To query the possible actin dependence of CYRI-A localiza-
tion, we treated COS-7 and HEK293T cells expressing both CYRI-
A and LifeAct with 1 µM of Latrunculin A (Yarmola et al., 2000;
Fig. 5 L and Video 6, clips 1 and 2). Within 30 s of addition, the
actin cytoskeleton diminished greatly, but CYRI-A cups/vesicles
were still frequently observed, even without any obvious
membrane ruffles, and cells still showed large dextran-positive
cups/vesicles (Video 6, clips 3 and 4), suggesting that even with
reduced actin accumulation, CYRI was recruited to the macro-
pinocytosis events that occurred. This suggested that CYRI-A
might not directly depend on actin for its localization. However,
Latrunculin A decreased the lifetime of CYRI-A at macro-
pinocytic structures by approximately twofold in both COS-7
and HEK293T cells (Fig. 5 L and Video 6, clips 3 and 4), sug-
gesting a positive feedback loop between actin and CYRI-A.
Since Latrunculin A can activate the Scar/WAVE complex by
an unknown mechanism (Weiner et al., 2007; Millius et al., 2009),
which could potentially influence the behavior of CYRI-A, we also
used Cytochalasin D (Schliwa, 1982), which showed a similar re-
sponse (Fig. 5 M). Overall, these data suggest that CYRI-A is re-
cruited tomacropinocytic cups or nascentmacropinosomes to RAC1
and Scar/WAVE-mediated actin assembly. CYRI-A’s lifetime, but
not its recruitment, is actin dependent. This fitswith our hypothesis
for CYRI-A as a local inhibitor of actin assembly at nascent mac-
ropinosomes, which drives completion of macropinocytosis.
CYRI-A regulates actin dynamics via interaction with RAC1
during macropinocytosis
We next asked how dynamics of CYRI-A compared with RAC1 dy-
namic recruitment during macropinocytosis. Cells overexpressing
GFP-RAC1 were broadly spread and displayed membrane ruffles
(Fig. 6 A), with RAC1 signal enriched in ruffles and folds (Fig. 6 A
and Video 7, clip 1). These ruffles folded onto themselves and
formed macropinosomes (Fig. 6 A, yellow arrowhead). Impor-
tantly, the CYRI-A signal was diffuse during the very early phase
where the RAC1 signal was first observed and before we ob-
served a closed-loop structure resembling a cup. However, as the
RAC1 signal gradually accumulated (for ∼50 s), it was followed
by a sharp increase in the CYRI-A signal, frequently on irregu-
larly shaped loop structures (Fig. 6, B and C). The increase in
CYRI-A signal preceded the immediate drop in the RAC1 signal,
and then both signals disappeared, as the macropinocytic cup
progressed toward an enclosed vesicle that was carried into the
cell. The timing of RAC1 accumulation matched closely to the
timing of filamentous actin accumulation on these cups (Fig. 5,
B–D), suggesting a mechanistic connection between CYRI-A,
RAC1, and actin. We next examined the localization of active
RAC1 relative to CYRI-A, using a CFP-tagged Pak-binding domain
(PBD; Fig. 6, D and E; and Video 7, clip 2). Cells expressing the
PBD probe showed some attenuation of macropinocytic events,
but when events occurred, PBD signal accumulated as the cups
matured, and before the peak of PBD, there was a sharp burst of
CYRI-A signal before both dissipated. It is important to empha-
size that all of these events happened locally on the macro-
pinocytic cups and that the peak of CYRI-A and RAC1 occurred
most frequently on peripherally located, irregularly shaped
structures resembling macropinocytic cups and early nascent
macropinosomes. We queried whether CYRI-A’s ability to bind
active RAC1 was important for its recruitment to nascent mac-
ropinosomes by using the RAC1-binding defective mutant RRDD
(Yelland et al., 2021). We cotransfected COS-7, HEK293T, or
CHL-1 cells with the WT P16-GFP-CYRI-A and either the WT or
the mutant RRDD construct of P16-mCherry-CYRI-A (Fig. 6, F–K;
Video 7, clips 3 and 4; Fig. S3, E and F; and Video 3, clips 5 and 6).
In all cases, GFP-tagged and mCherry-tagged WT CYRI-A colo-
calized at every macropinocytic event captured. In contrast,
mutant CYRI-A did not colocalizewith itsWT counterpart on any
of the macropinocytic events. Overall, these data strongly sug-
gest that CYRI-A is locally recruited to macropinocytic structures
as they form and with similar dynamics to RAC1, dependent on
the RAC1 binding motif in CYRI-A.
Recruitment of CYRI-A during macropinocytosis is dependent
on PI3K signaling
PI3K signaling plays an important role during macropinocytosis,
as phosphatidylinositol (3,4,5)-trisphosphate (PIP3) production
efficiency of single KO and DBKO of CYRIs. GAPDH as loading control. (C)Quantification of cell shape (left) and spread area (right) of A from at least 50 cells per
experiment from three independent experiments. Mean ± SD. One-way ANOVA with Tukey’s multiple comparison test. ns, P > 0.05; **, P < 0.01; ****, P <
0.0001. (D and E) Migration analysis of CYRI CRISPR cells on a 2D fibronectin substrate (random migration) or in 3D CDM. Data from at least 30 cells per
experiment from three independent experiments. Each experiment is color-coded. Mean ± SD. One-way ANOVA with Tukey’s multiple comparison test. ****,
P < 0.0001. (F) Reexpression of CYRI-A in DBKO A-673 cells reduces their speed to the original values but does not affect the control pLKO cells. Data from at
least 30 cells per experiment from three independent experiments. Each experiment is color-coded. Mean ± SD. One-way ANOVA with Tukey’s multiple
comparison test. ns, P > 0.05; ****, P < 0.0001. (G and H)Wound healing assay comparing the control pLKO, single KO, and DBKO CYRI cells. Data from at least
four independent experiments. Each experiment is color-coded. Mean ± SD. One-way ANOVA with Tukey’s multiple comparison test. ns, P > 0.05; ***, P <
0.001; ****, P < 0.0001. Orange dotted lines highlight the edge of the cell monolayer. (I) Proliferation assay using the Incucyte system of control pLKO, single
KO, and DBKO CYRIs in A-673 cells. Data from at least three independent experiments. Mean ± SEM.
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has been shown to recruit many RAC1 guanine nucleotide ex-
change factors (GEFs; Araki et al., 2007; Campa et al., 2015;
Bloomfield and Kay, 2016; Bohdanowicz and Grinstein, 2013).
We visualized PIP3 using two independent reporters, PH-Grp1
(Lai et al., 2013; Kavran et al., 1998) and PH-Btk (Araki et al.,
2007; Várnai et al., 2005), alongwith the internally tagged CYRI-A
construct in HEK293T cells. Remarkably, the PIP3 signal ap-
peared for ∼40 s on what appeared to be irregularly shaped cups
forming at the periphery of the cell and peaked before the CYRI-A
signal slowly appeared (Fig. 7, A–F; and Video 8, clips 1 and 2).
COS-7 cells were similar, although PIP3 reporters sometimes also
localized to tubules clumping together (Fig. S3, G–L; and Video 3,
clips 7 and 8). Our observations fit nicely with the consensus
model where PIP3 recruited RAC1 GEFs, which activated RAC1
and drove actin polymerization (Buckley and King, 2017;
Swanson and Watts, 1995; Bloomfield and Kay, 2016), and the
recruitment of CYRI-A could dampen down this signaling path-
way. Blocking PI3K activity using 20 µM LY294002 almost
completely disrupted the recruitment of CYRI-A to the cups/
vesicles in COS-7 cells (Fig. 7, G andH; and Video 8, clips 3 and 4).
It is interesting to note that cells treated with LY294002 still
displayed low levels of membrane ruffles (Araki et al., 1996), but
both the diffused and localized recruitment of CYRI-A was
completely abolished. This fits in with a previous observation
that LY294002 blocked the resolution of macropinocytic cups
(Araki et al., 1996). Interestingly, mScarlet-Lck (Chertkova et al.,
2020 Preprint) marked the plasma membrane, which invagi-
nated for 50 s before CYRI-A was recruited (Fig. S3, M and N;
and Video 3, clip 9). The CYRI-A signal appeared coincidently
with the loss of plasma membrane identity of the structures,
indicating cup closure and detachment of the vesicles into the
cytoplasm. This suggests that the CYRI-A signal coincides with
the transition from a macropinocytic cup at the plasma mem-
brane into an enclosed vesicle that is then transported into the
cell. Overall, the function of CYRI-A is strongly dependent on
PI3K-PIP3 activity, which may be due to the central role of PI3K-
PIP3 in macropinocytic cup formation.
CYRI proteins affect the trafficking of integrin α5β1
One of the major cargoes of macropinocytic uptake is integrins
(Caswell et al., 2009; Gu et al., 2011; De Franceschi et al., 2015).
Furthermore, the broad lamellipodial phenotype of CYRI DBKO
cells suggested a possible enhancement of integrin-based adhe-
sion. We queried whether CYRI proteins could impact adhesion
and integrin trafficking. using the xCELLigence adhesion assay
based on impedance to show that CYRI DBKO A-673 cells spread
approximately twofold more efficiently than single KOs or
controls (Fig. 8, A and B). Flow cytometry analysis revealed an
almost 50% increase in the surface expression of integrin α5 and
β1 in two independent CYRI DBKO A-673 cell lines compared
with control pLKO (Fig. 8, C and D). Western blotting showed a
minor but consistent increase of the total level of integrin α5 and
β1, but quantitative real-time PCR (qPCR) analysis showed no
obvious change in their mRNA levels (Fig. 8, E and F). We de-
tected a similar increase for the active integrin α5 using the
SNAKA51 antibody with flow cytometry, but no change for the
level of the membrane metalloprotease MT1MMP (Fig. S4, A and
B). Immunofluorescence analysis revealed a significant increase
in both the area of adhesion sites as well as their number per cell
in the CYRI DBKO cells compared with the controls (Fig. 8, G and
H; and Fig. S4, C–E). Overexpression of P16-GFP-CYRI-A in the
DBKO cells rescued these phenotypes (Fig. 8, I and J), while the
non-RAC1-binding mutant failed to rescue the phenotype of
CYRI-B KO in COS-7 cells (Fig. S4, F–H; and Video 9, clip 3).
Overall, we find that loss of both CYRI isoforms in A-673 cells
leads to the enhanced display of surface integrins, suggesting a
defect in their intracellular trafficking.
Integrin α5 and β1 are localized to CYRI-positive cups and
vesicles
Since CYRIs are involved in macropinosome formation and
macropinocytosis is one of the major effectors of bulk inter-
nalization of integrins (Caswell et al., 2009; Gu et al., 2011; De
Franceschi et al., 2015), we next asked whether integrins colo-
calized with CYRI proteins at these structures. We first coex-
pressed an mApple-tagged integrin α5 construct along with the
P16-GFP-CYRI-A or P17-GFP-CYRI-B in COS-7 cells (Fig. 9, A and
B; and Video 9, clips 1 and 2) or HEK293T cells (Fig. S4 F). In-
tegrin α5 decorated many intracellular cups/vesicles, including
CYRI-A–positive macropinocytic cups/vesicles formed near the
edge of the cells (Fig. 9 A). CYRI-B also decorated tubules ema-
nating from the tips of filopodia-like protrusions (Fig. 9 B). Integrins
also colocalized with CYRI-A– and CYRI-B–positive macropinocytic
structures in COS-7 (Fig. 9, C–H) as well as in the DBKO A-673 cells
(Fig. S4, J–M).
Increased surface presentation of integrin α5 and β1 sug-
gested a potential defect in internalization, perhaps due to the
requirement for CYRI proteins in the resolution of macro-
pinocytic structures. To address this, we performed an inter-
nalization assay of the active integrin α5. Control cells showed a
significant increase in internalized signal after 30 min (Fig. 9, I
and J). Expression of the P16-GFP-CYRI-A in CYRI DBKO A-673
Figure 4. CYRI-A localizes to large macropinocytic cup-like structures before RAB5A recruitment. (See Video 1.) (A–C) P16-GFP-CYRI-A in HEK293T
(scale bar = 20 µm; n = 204 events in 18 cells for cups/vesicles and n = 24 events in 10 cells for tubules) decorates structures resembling macropinocytic cups
(yellow arrowheads, diameter ranging from 0.4 to 2.9 µm; scale bar = 5 µm). Tubule length 0.7–7 µm. Average lifetime of CYRI-A on cups, 50 s (n = 58 events in
5 cells). Red lines represent the average value. (D) Still images of COS-7 cells (scale bar = 20 µm) expressing P16-GFP-CYRI-A showing the diffuse pool of CYRI-A
(yellow doubled arrow) near the leading edge. Dotted square denotes time sequence on the right (scale bar = 5 µm). (E) Time-lapse sequence of COS-7 cells
expressing P16-GFP-CYRI-A (cyan) and mCherry-RAB5A (magenta). Scale bar = 20 µm (full size) or 5 µm (zoom). (F and G) Time sequence of CYRI-A and RAB5A
recruitment to the macropinocytic cups (CYRI-A only, n = 75 events in 8 cells; CYRI-A with RAB5A, n = 68 events in 8 cells). (H–J) Dextran uptake assay
(scale bar = 5 µm). Quantification of the percentage of CYRI-A–positive cups/vesicles containing dextran (n = 9 cells) and the size (cups/vesicles, n = 15
events in 7 cells; tubules, n = 10 events in 7 cells). Two-tailed unpaired t test.
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Figure 5. CYRI-A regulates actin dynamics at macropinocytic structures. (See Video 4, Video 5, and Video 6.) (A) Still images of COS-7 cells coexpressing
either GFP (negative control) or P16-GFP-CYRI-A (cyan) and LifeAct-RFP (magenta). Scale bar = 10 µm for full-sized image and 5 µm for zooms. (B) Time
sequence images showing the dynamics of P16-GFP-CYRI-A and actin at the macropinocytic structure in COS-7 cells. Graph shows normalized signal intensities
Le et al. Journal of Cell Biology 10 of 25
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cells rescued their integrin internalization defect, while
treating with LY294002 significantly decreased the internal-
ized signal (Fig. 9, K–N). This strongly suggests the role of
macropinocytosis in contributing to integrin internalization
in these cells. Overall, our data support a novel function of
CYRIs in cooperatively regulating the trafficking of integrin
α5β1 through the enhancement of actin dynamics during
macropinocytosis to allow the efficient internalization of surface
integrins.
CYRI DBKO A-673 cells are more invasive and resistant to
anoikis due to the increased level of surface integrins
Increased levels of α5 and β1 integrins have been associated with
increased invasiveness and survival of multiple types of cancer
(Bianchi-Smiraglia et al., 2013; Clark et al., 2005; Mierke et al.,
2011; Nam et al., 2010; Paul et al., 2015). Building on these ob-
servations and our migration data (Fig. 3, D–H; and Fig. S1, F and
G), we tested the invasive capacity of the CYRI DBKO A-673 cells
into collagen plugs (Timpson et al., 2011). Loss of CYRI proteins
significantly increased invasion by approximately threefold
(10% for DBKO and 3% for controls; Fig. 10, A and B). Blocking
the activity of the integrin α5β1 using the blocking antibody IIA1
dramatically reduced the invasion of the DBKO cells, but not
controls, into collagen-Matrigel-fibronectin (CMF) plugs in in-
verted invasion assays (Fig. 10, C and D). Individually inhibiting
each subunit with specific blocking antibodies also reduced in-
vasion (Fig. S5, A and B). On a 2D surface, pretreating cells with
IIA1 blocking antibody significantly reduced their ability to ad-
here and spread on fibronectin matrix (Fig. S5, C and D). This
suggested that in CYRI DBKO cells, integrins play a crucial role
in regulating shape and adhesion. Treatment with this antibody,
however, only affected the migration ability of the DBKO cells,
but not the control pLKO, in a 2D random migration assay (Fig.
S5 E), in agreement with our invasion data (Fig. 10, C and D).
Integrins also provide cancer cells with increased resistance to
anoikis, a programmed cell death process triggered by the lack of
adhesions, through triggering FAK activation on the endosomal
membrane (Alanko et al., 2015). Culturing the control and two
DBKO cell lines in the low-attachment condition of agarose
showed that indeed the DBKO cells formed larger colonies
(Fig. 10, E and F). Overall, our data provide a mechanism linking
the function of CYRIs in macropinocytosis to the invasive ca-
pacity of cancer cells through modulating integrin trafficking
and signaling (Fig. S5 F).
Discussion
CYRI proteins specifically bind to RAC1 and oppose recruitment
and activation of Scar/WAVE complex in lamellipodia (Fort
et al., 2018). Fort et al. (2018) showed that CYRI-B can de-
crease RAC1 activation in cells by an unknown mechanism and
likely sequester RAC1 away from interactionwith Scar/WAVE or
somehow disrupt RAC1 signaling to Scar/WAVE (Fort et al.,
2018). However, the cellular functions of the related protein
CYRI-A have never been specifically described, and nothing is
known about the dynamics of CYRI proteins in live cells. CYRI-A,
encoded by the FAM49A gene, has previously been linked to
nonsyndromic oral clefts and craniofacial abnormalities (Chen
et al., 2018; Leslie et al., 2016; Azevedo et al., 2020), suggesting an
important role in developmental and perhaps morphogenetic
processes, but a mechanistic understanding of its cellular func-
tion is currently missing. Here, we model CYRI-A into the re-
cently solved structure of CYRI-B (Yelland et al., 2021; Kaplan
et al., 2020) and show that the overall structure is likely similar.
We show biochemically that CYRI-A interacts specifically with
active RAC1 via a conserved double arginine motif, but with a
higher affinity than CYRI-B. CYRI-A expression can rescue the
effects of CYRI-B deletion on lamellipodia and spreading, re-
flecting that they likely have overlapping functions. Depletion of
both CYRI-A and CYRI-B together has a stronger effect on la-
mellipodia and cell migration than depletion of either protein
independently. We thus place CYRI-A as a paralog of CYRI-B,
with broadly similar behavior, including specifically interacting
with active RAC1 and opposing recruitment and activation of
Scar/WAVE complex at the leading edge of cells. We also de-
veloped a new tool to study for the first time the dynamics of
CYRI proteins, which revealed an unexpected dynamic role of
CYRI-A in the early stages of macropinocytosis, during cup for-
mation and internalization, with implications for integrin traf-
ficking, cell migration, and invasion.
The interplay between signaling and cytoskeletal dynamics
that drives macropinocytosis involves PI3K activation and PIP3
signaling, leading to the activation of RAC1 (likely via recruit-
ment of a RAC1 GEF) and thus the Scar/WAVE complex. The
resulting actin assembly drives the formation of membrane
ruffles and macropinosomes (Veltman et al., 2016). As we pre-
viously found that CYRI-B enhances dynamics at the leading
edge of the cell by opposing actin-driven membrane expansion
(Fort et al., 2018), it is also possible that CYRI has a direct role in
promoting membrane ruffling that leads to macropinocytic cup
over time. Black arrows denote peak actin and CYRI-A signals. Scale bar = 5 µm. (C) Normalized signal intensities over time between P16-GFP-CYRI-A and
LifeAct signal in HEK293T cells. (D) Lifetime of actin before and after P16-GFP-CYRI-A is recruited in HEK293T cells (before CYRI-A, n = 25 events in 10 cells;
with CYRI-A, n = 34 events in 10 cells). Red lines indicate the average value. (E–G) Lifetime of actin on macropinocytic structures ± expression of P16-GFP-CYRI-A
in CYRI DBKD COS-7 cells. Scale bar = 1 µm. Number of actin-positive structures in cells ± P16-GFP-CYRI-A expression (n = 9 cells; F). Lifetime of the actin signal
on macropinocytic structures ± P16-GFP-CYRI-A signal (actin alone, n = 43 events in 9 cells; actin with CYRI-A, n = 33 events in 8 cells). (H) Macropinocytosis
assay in siRNA-treated COS-7 cells. Scr, scramble. Black dots are internalized dextran. Black dashed lines indicate the boundary of the cell clusters. Scale bar =
30 µm. (I) Macropinocytic index of H. Data are from at least 10 different fields of view per experiment from a total of three independent experiments (color-
coded by experiment). Two-tailed unpaired t test. Mean ± SD. (J and K) Expression of P16-mCherry-CYRI-A in control COS-7 cells, DBKD COS-7 cells, and P16-
mCherry-CYRI-A RRDD mutant (non-RAC1 binding mutant) cells showing dextran 70-kD uptake capacity of the cells. Data are from ≥10 different fields of
view for a total of three independent experiments. Each experiment is color-coded. Mean ± SD. Kruskal–Wallis test with Dunn’s multiple comparison
test. ns, P > 0.05. (L and M) Lifetime of P16-GFP-CYRI-A on macropinosomes ± 1 µM of Latrunculin A (LatA) or Cytochalasin D (CytoD) in COS-7 and
HEK293T cells. At least five cells per experiment from three independent experiments (color-coded). Mean ± SD. Mann–Whitney U test.
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Figure 6. CYRI-A is recruited to macropinocytic structures by active RAC1. (See Video 7.) (A–C) Time sequence images of HEK293T cell coexpressing P16-
mCherry-CYRI-A (cyan) and GFP-RAC1 WT (magenta). (B) Normalized signal intensity of RAC1 and CYRI-A at macropinocytic structure. (C) Lifetime of RAC1
signal on themacropinocytic structures (n = 37 events in 4 cells). Scale bar = 10 µm for full-sized image and 5 µm for zooms. (D and E) Time sequence images of
Le et al. Journal of Cell Biology 12 of 25
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formation. This could imply coordinating with PI3K, which
drives dorsal ruffle structures (Corallino et al., 2018), but this
requires further study. We observed dynamic recruitment of
CYRI-A at macropinocytic cups, persisting until after engulf-
ment. While we were not able to distinguish whether CYRI-A is
present both before and after cup closure, using markers of the
various stages of macropinocytosis, we placed CYRI-A after PI3K
and immediately downstream of RAC1 activation and the initi-
ation of actin assembly at the forming macropinocytic cup.
CYRI-A is recruited before and only briefly present coinciden-
tally with RAB5A, a marker of the early endosomes. By contrast,
CYRI-B appeared to be more evenly distributed at the plasma
membrane and on internal tubular and vesicular structures. So,
while CYRI-A and CYRI-B can compensate for each other in
aspects of cell motility, they appear to be differently regulated.
However, we cannot rule out that the internally inserted fluo-
rescent protein tag affects CYRI-A and CYRI-B differently and
might affect their localization or even their activity.
Both the activation and deactivation of RAC1 are required for
the completion of macropinocytosis. For example, when RAC1
activation is sustained using photoactivation, themacropinocytic
cups were arrested until RAC1 activation was switched off (Fujii
et al., 2013). In macrophages, RAC1 GAPs are frequently paired
with GEFs (Denk-Lobnig and Martin, 2019) and are needed for
the completion of phagocytosis of large particles (Schlam et al.,
2015), presumably to shut down RAC1 signaling and to allow
actin disassembly. However, a specific inhibitor of RAC1 at the
macropinocytic cup has never been discovered. Here, we show
that CYRI-A rapidly accumulates on macropinocytic cups and
nascent macropinosomes harboring activated RAC1, where it
presumably sequesters RAC1 or disrupts its activity toward Scar/
WAVE, promoting actin disassembly. Our studies suggest that
CYRI-A and actin form a feedback loop, as blocking actin dy-
namics using Latrunculin A or Cytochalasin D decreased CYRI-
A’s lifetime on the cups/vesicles, while the presence of CYRI-A
decreased the lifetime of actin. Interestingly, a proteomic analysis
of macropinosomes done in Dictyostelium also implicated CYRI
(then known only as Fam49; Journet et al., 2012), suggesting that
this function is likely to be conserved.
We speculate that CYRI-A opposing Scar/WAVE and actin
dynamics is important for the loss of the dense actin coat around
the newly formed/forming macropinosome to allow it to move
inside of the cell and begin its maturation process. The actual
mechanism of how CYRI proteins oppose RAC1 activation of
Scar/WAVE complex still needs further study. While CYRI
proteins are present in cells at sufficient concentrations to
compete with Scar/WAVE complex (Fort et al., 2018), they show
a relatively low affinity in vitro for RAC1, and we have not
detected GTPase activating activity toward RAC1 directly
(unpublished data). It would be interesting to know if CYRI-A
cooperates with another recently described regulator of actin
on macropinosomes, Phafin2 (Schink et al., 2017 Preprint).
Phafin2 is described as a coincidence detecting protein im-
portant for the removal of the actin coat and, as such, may have
interplay with CYRI proteins.
DBKD of CYRI-A and CYRI-B gave a robust enhancement of
cell spreading and concomitant increase in surface α5β1 in-
tegrin. Integrins are internalized by multiple different routes,
including macropinocytosis (Gu, et al., 2011) and the CLIC-GEEC
pathway (Moreno-Layseca et al., 2020 Preprint), where they can
be rapidly recycled back to the surface or targeted for degra-
dation in lysosomes (Yu et al., 2012; Zech et al., 2011). It is
unclear whether certain routes of uptake, such as clathrin-
mediated endocytosis or macropinocytosis, might favor degra-
dation versus recycling, but we find that by either depleting
CYRIs or treating cells with PI3K inhibitor LY293002, we slow
down the internalization of active integrin as detected with the
SNAKA51 antibody (Fig. 9). The SNAKA51 antibody prefer-
entially recognizes active integrin α5β1 at fibrillar adhesions
that are bound to fibronectin (Clark et al., 2005). Active
ligand-bound α5β1 integrin is also internalized in an Arf4-
Scar/WAVE–dependent manner for trafficking to lysosomes
(Rainero et al., 2015). Integrin engagement and recycling are
important regulators of cancer cell invasive migration (Yu et al.,
2012; Caswell et al., 2008; Dozynkiewicz et al., 2012; Paul et al.,
2015). Loss of CYRI-A and -B promoted cancer cell invasion,
presumably because of excess active integrins on the cell surface
and perhaps higher overall levels of RAC1 activation and en-
gagement of the Scar/WAVE complex at the cell’s leading edges.
We cannot, however, entirely rule out the effects of other en-
docytic pathways in contributing to integrin trafficking in our
KO cells. Future experiments should address in more detail the
connection between CYRI-mediated endocytosis with other
pathways such as clathrin-mediated endocytosis, one of the
major integrin trafficking processes. Also, given the role of CYRIs
inmembrane dynamics, it would be interesting to study whether
CYRIs could affect the mechanical properties of the cells. Given
the larger spreading area and the higher level of surface inte-
grins, one might speculate an effect of CYRI KO on membrane
tension, which could also result in changes in membrane re-
ceptor trafficking. While our study implicates CYRI proteins in
trafficking of integrins via macropinocytosis, we do not think it
likely that integrins are the only cargo, as macropinocytosis in-
volved uptake of multiple membrane receptors.
Overall, our study points to CYRI proteins as regulators of
actin dynamics not only at the plasma membrane for lamelli-
podia dynamics, as previously described (Fort et al., 2018), but
also as regulators ofmacropinocytic uptake. Ourmodel in Fig. S5 F
describes how CYRI-A is specifically recruited from amore diffuse
localization to bright flashes appearing at the ruffle-to-cup and
HEK293T cell coexpressing P16-GFP-CYRI-A (cyan) and CFP-PBD (magenta). (E) Normalized signal intensities of CYRI-A and PBD over time. Scale bar = 10 µm
for full-sized image and 5 µm for zooms. (F–K) Time sequence images of HEK293T cells coexpressing either WT or RRDD mutant of P16-mCherry-CYRI-A
(magenta) with theWT P16-GFP-CYRI-A (cyan; F and I). Colocalization of the signals between the twoWT constructs (G) and lack of colocalization betweenWT
and mutant constructs (J). Percentage of colocalization events (n = 5 cells; H and K). Scale bar = 10 µm for full-sized image and 5 µm for zooms. Two-tailed
unpaired t test. Mean ± SEM. **, P < 0.01; ****, P < 0.0001.
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Figure 7. CYRI-A’s recruitment to macropinocytic structures is dependent on PI3K signaling. (See Video 8.) (A–F) HEK293T cells were cotransfected
with P16-mCherry-CYRI-A (cyan) and either GFP-PH-Grp1 (magenta) or GFP-PH-Btk (magenta) as specific markers for PIP3 (A and D). Line graphs show the
sequential events between PIP3 reporters and CYRI-A (B and E). Black arrows indicate the peaks of each normalized signal. Scatter plots show the average
lifetime of PIP3 reporter signal before CYRI-A is recruited to macropinocytic structures (Grp1, n = 9 events in 3 cells; Btk1, n = 57 events in 6 cells). Red lines
represent the average value. Scale bar = 10 µm for full-sized images and 5 µm for zooms. (G and H) Time sequence images showing COS-7 cells expressing
P16-GFP-CYRI-A before and after the addition of 20 µM of LY294002. Quantification shows a significant decrease in the number of P16-GFP-CYRI-A–positive
cups/vesicles formed upon PI3K inhibition (n = 9 cells). Scale bar = 10 µm. Statistical analysis using paired t test.
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Figure 8. CYRI-A and CYRI-B cooperatively regulate matrix attachment and surface expression of integrin α5β1 in A-673 cells. (A and B) Repre-
sentative immunofluorescence images of A-673 cells comparing the spreading propensity between the control pLKO and the CYRI DBKO cells on fibronectin
Le et al. Journal of Cell Biology 15 of 25
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early vesicle stages of macropinocytosis. CYRI-A binds to and is
recruited by its interaction with active RAC1, similar to the pre-
viously described “local inhibitor” postulated byMeinhardt (1999).
Thus, the activation signal also triggers local recruitment of an
inhibitor, CYRI-A, which opposes the activation of Scar/WAVE
complex by RAC1 and facilitates the closing and engulfment of
macropinocytic cups and the loss of the dense actin meshwork
that was underpinning the ruffle protrusions. We show that CYRI
proteins’ role in macropinocytosis impacts on the level of surface
integrins displayed on cells and thus their ability to adhere,
spread, and invade into 3D matrix. This could have important
implications for cancers where RAC1 pathways are disrupted or
enhanced, such as inmelanomaswhere RAC1 activatingmutations
are considered to be drivers (Cannon et al., 2020).
Materials and methods
Cell line generation, maintenance, and growth conditions
COS-7, CHL-1, and HEK293T cells were grown in DMEM
(#21969-035; Gibco) supplemented with 10% FBS (#10270-106;
Gibco), 1× glutamine (#25030-032; Gibco), and 1× penicillin/
streptomycin (#15140122; Life Technologies). A-673 cells were a
kind gift from Dr. Susan Burchill (Leeds Institute, Leeds, UK)
and were grown in the same medium but with 0.5× glutamine.
Single CYRI CRISPR A-673 was generated using Lentiviral
CRISPR vector (hSpCas9-2A-Puro, #62988; Addgene) and se-
lected using 1 µg/ml puromycin (#ant-pr-1; InvivoGen) for 1 wk.
Double CYRI CRISPR A-673 was generated using a combination
of the hSpCas9-2A-Puro and a modified version containing a
Blasticidin resistant gene (a kind gift from Dr. Stephen Tait,
CRUK Beatson Institute, Glasgow, UK). DBKO cells were selected
by using a combination of 1 µg/ml puromycin and 6 µg/ml
Blasticidin (#ant-bl-10p; InvivoGen) for 1 wk.
For maintenance, cells were kept in the presence of all an-
tibiotics to prevent incomplete selection. For passaging, cells
werewashedwith PBS, and 500 µl of 0.25% trypsin (#15090046;
Gibco) was added and incubated at 37°C for 2 min. Trypsin was
blocked by adding 5 ml medium containing 10% serum, and cells
were split in a 1:10 ratio on day 1 and 1:5 on day 5. For experi-
mental testing, cells were grown in antibiotic-free medium.
Cells were grown at 37°C in a 5% CO2 incubator.
For all experiments with multiple repeats, cells of different
passages were considered biological replicates. Cells of different
origins (HEK293T, COS-7, and CHL-1) were used to confirm the
reproducibility of our observations in live-cell imaging experi-
ments. All cells were from ATCC and were authenticated using
short tandem repeat profiling. All cells were tested for myco-
plasma with qPCR and were confirmed to be negative.
sgRNA and siRNA
sgRNAs for CRISPR were designed using the Zhang laboratory
website (https://zlab.bio/guide-design-resources) and were then
purchased through Thermo Fisher Scientific: h49A-sgRNA2.1, 59-
CACCGCCTGAAGGACGGCGCTGATC-39; h49A-sgRNA2.3, 59-CAC
CGCTGCAGGCTTACAAAGGCGC-39; and h49B-sgRNA4.1, 59-CAC
CGCGAGTATGGCGTACTAGTCA-39. siRNAs were purchased from
Qiagen: Hs_FAM49A_5 FlexiTube siRNA (#SI03150210), 59-ATC
GATATGAAAGGCTGCATA-39; Hs_FAM49A_9 FlexiTube siRNA
(#SI05122656), 59-CAGATTGATGTTAATACTTGT-39; Hs_FAM49B_7
FlexiTube siRNA (#SI04359369), 59-ATAGAAGAACATTGAGTCGT
A-39; and AllStars Neg. Control siRNA (20 nmol; #0001027281).
For CRISPR gene deletion, lentivirus containing the CRISPR-
Cas9 construct was generated using HEK293T cells. In brief, 1.5 ×
106 HEK293T cells were plated on a 10-cm Petri dish. Cells were
transfected with 10 µg of CRISPR construct containing sgRNA
targeting the gene of interest, 7.5 µg of pSPAX2, and 4 µg of
pVSVG packaging plasmid using standard calcium precipitation
protocol (#K278001; Invitrogen) and grown in 20% serum-
containing medium for 24 h. Conditioned medium was filtered
through a 0.45-µm filter and mixed with 2.5 µl polybrene per
6 ml of conditioned medium before being added to the targeting
cells. The infection process was repeated a second time before
antibiotics were added for 1 wk for selection.
For siRNA gene silencing, one reaction, 20 nmol of siRNA
was mixed with 7 µl of Lullaby (#LL71000; Oz Biosciences) and
incubated in serum-free medium in a total volume of 200 µl for
20 min before adding to 3 × 105 cells growing in 1,800 µl of
medium. The process was repeated after 48 h, and cells were
split if becoming too confluent. 24 h after the second treatment,
cells were used for further experiments.
Lipofectamine plasmid transfection
For one reaction, 2 µg of DNA plasmid was mixed with 5 µl of
Lipofectamine 2000 (#11668019; Thermo Fisher Scientific) in
serum-free medium to a total volume of 200 µl and incubated at
room temperature for 5 min before adding to 3 × 105 cells in a
six-well plate. Cells were incubated at 37°C, 5% CO2, and the
transfection efficiency was assessed after at least 18 h.
Cell fixation and immunofluorescence
Glass coverslips were treated in 70% HNO3 (nitric acid) for
30 min before washing with a copious amount of water. Cov-
erslips were then coated with 1 mg/ml of fibronectin (#F1141;
Sigma-Aldrich) for 2 h and washed with PBS. Cells were seeded
on coverslips and left to settle for 4 h before being fixed in 4%
PFA. Cells were permeabilized with buffer containing 20 mM
glycine and 0.05% Triton X-100 in PBS for 5 min before being
(A). Scale bar = 40 µm. Graph shows a time course of cell–matrix attachment for control pLKO (blue), the single KO (green and orange), and the DBKO cells.
(C and D) Flow cytometry analysis (C) and quantification (D) of the surface expression of integrin α5β1 in A-673 cells between control pLKO and the DBKO cells
(DBKO1 and DBKO2). (E and F) Representative Western blot of the total level of integrin α5β1 in DBKO cells compared with control pLKO or single KO cells (E).
qPCR analysis for gene expression of integrin α5β1 in pLKO and the DBKO cells (F). (G and H) Immunofluorescence images of the surface level of integrin α5β1
between the control pLKO and DBKO cells (#1 and #2; G). Scale bar = 10 µm. The quantification is shown in H. Data from ≥10 cells per experiment in a total of
three independent experiments. Each experiment is color-coded. (I and J) Effect of CYRI-A expression in DBKO cells on area and number of integrin adhesion
sites. Data from ≥10 cells per experiment in a total of three independent experiments. Each experiment is color-coded. For all graphs, mean ± SD. Statistical
analysis using one-way ANOVA with Tukey’s multiple comparison test.
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Figure 9. CYRI-A and CYRI-B cooperatively regulate the internalization of integrin α5β1. (See Video 9.) (A and B) Time sequence images of COS-7 cells
coexpressing either P16-GFP-CYRI-A or P17-GFP-CYRI-B and mApple-tagged integrin α5. Scale bar = 10 µm for full-sized image and 5 µm for zooms.
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incubated with primary antibody (1:200 dilution) and then
secondary antibodies (1:200 dilution), phalloidin (1:100 dilu-
tion), and DAPI (1:1,000 dilution). Cells were then mounted on a
glass slide using ProLong Diamond AntifadeMountant (#P36961;
Invitrogen).
CYRI-B CRISPR COS-7 cell CYRI-A rescue experiments
CYRI-B CRISPR COS-7 cells were transfected with a control GFP-
FLAG or CYRI-A-FLAG construct using Lipofectamine protocol
for 24 h before cells were seeded on acid-treated fibronectin-
coated coverslips for 4 h. Cells were fixed and stained using
the immunofluorescent protocol described above. The av-
erage Arp2/3 signals at the cell periphery of the transfected
cells was measured using the freehand selection tool with a
width of 1 pixel on 8-bit images. The cell spread area was
measured by manually outlining the selected cells, then the
background was removed before a constant threshold was
applied.
Cell shape analysis
A-673 cells, either CRISPR/Cas9 KO or siRNA treated, were
plated on fibronectin-coated coverslips for 4 h before being fixed
and stained for DAPI and phalloidin as described above. Images
were acquired using a Zeiss710 20× objective. At least 10 random
fields of view per sample were imaged. All images were then fed
into CellProfiler 3.0.0 software to measure the spreading area.
Integrin immunofluorescent quantification
A-673 cells were seeded on fibronectin-coated coverslips over-
night. The next day, the cells were fixed and stained using the
immunofluorescence protocol described above. The number and
size of integrin adhesion sites were extracted using the auto-
threshold function RenyiEntropy white in ImageJ applied on
8-bit images. The number of integrin adhesion sites was the
absolute number per cell. The size was normalized to the size of
the selected cell.
Image-based integrin internalization assay
The assay was based on the internalization assay described in
Pietilä et al. (2019) with a slight modification. In brief, A-673
cells were grown on fibronectin-coated coverslips overnight to
allow the cells to fully adhere. The next day, cells were washed
with ice-cold PBS and incubated with SNAKA51 antibody in ice-
cold HBSS (8 g NaCl, 0.4 g KCl, 0.14 g CaCl2, 0.1 g MgSO4.7H2O,
0.1 g MgCl2.6H2O, 0.06 g Na2HPO4.2H2O, 0.06 g KH2PO4, 1.0 g
glucose, 0.35 g NaHCO3, and H2O to 1,000 ml) for 1 h on ice and
covered in aluminum foil. Internalizationwas induced by adding
1 ml of 37°C serum-free medium, and cells were quickly trans-
ferred to a 37°C incubator for 30 min. For the control as 0 min,
the unbound antibody was washed with ice-cold PBS before the
bound antibody was stripped using acid wash (0.2 M acetic acid
and 0.5 M NaCl, pH 2.5, in PBS) for 1.5 min. After 30 min, cells
were removed from the incubator and washed with 1 ml of ice-
cold PBS to terminate any endocytosis. Uninternalized anti-
bodies on the cells were acid-stripped, and both conditions were
fixed with 4% PFA. Cells were then subjected to our standard
immunofluorescence protocol as described above and stained for
DAPI and the secondary antibody for integrins. For image ac-
quisition, a z-stack of 0.18 µm per slice was taken with an Air-
yScan Zeiss880 using a Plan-Apochromat 63×/1.4 oil differential
interference contrast (DIC) M27 objective lens. Healthy cells
were selected based on the morphology of the nucleus. Acquired
images were deconvoluted using Zen Black software before
analysis. A maximum-intensity projection was generated using
the 3D Project function from ImageJ and then converted to an 8-
bit image. The pipeline for semiautomated quantification was
set up. The cell outline was manually drawn using the freehand
selections tool. The outside background was removed. The au-
tothreshold functionMaxEntropy in ImageJ was used to identify
internalized signals. Enhanced-contrast images were used to
define cell area. The level of internalization was quantified by
measuring the area of internalized signal and was normalized to
the area of the selected cell.
For the rescue experiment, CYRI DBKO A-673 cells were
transfected with either GFP or P16-GFP-CYRI-A overnight.
Cells were seeded on fibronectin-coated coverslips overnight
before being subjected to the same internalization assay proto-
col. A z-stack of 0.64 µm per slice was taken with an AiryScan
Zeiss880 using a Plan-Apochromat 63×/1.4 oil DIC M27 ob-
jective lens. The same pipeline was applied to quantify the
internalization signal using either MaxEntropy or Intermodes
for autothresholding.
For the inhibitor experiment, P16-GFP-CYRI-A–rescued CYRI
DBKO A-673 cells were used due to the control pLKO cells were
very sensitive to PI3K inhibition with LY294002. Rescued cells
were not induced for internalization, were induced for inter-
nalization for 30 min using 37°C serum-free medium, or were
induced for internalization in the presence of 10 µM of LY294002.
The same image acquisition and image analyses were applied for
quantification.
(C–H) Colocalization analysis of P16-GFP-CYRI-A or P17-GFP-CYRI-B (cyan) with endogenous integrin α5 or β1 (magenta) and actin (orange) in COS-7 cells.
Right panels (D, F, and H) are intensity graphs showing the colocalization of all three normalized signals at the cups/vesicles. Scale bar = 10 µm for full-sized
image and 5 µm for zooms. (I and J) Internalization assay of A-673 cells for active integrin α5 (SNAKA51, cyan) after 0- or 30-min incubation. (I) Representative
images of the internalized signal of active integrin α5 (SNAKA51, black dots). (J) Quantification of the area of the internalized signals. Data from three in-
dependent experiments of at least 10 cells per experiment. Each experiment is color-coded. Statistical analysis using one-way ANOVA with Tukey’s multiple
comparison test. Mean ± SD. Scale bar = 10 µm. (K and L) Reexpression of P16-GFP-CYRI-A in CYRI DBKO A-673 cells rescued the internalization defect in
these cells compared to cells expressing only GFP. (L) Quantification of K. Data from three independent experiments of at least 10 cells per experiment. Each
experiment is color-coded. Statistical analysis using one-way ANOVA with Tukey’s multiple comparison test. Mean ± SD. Scale bar = 10 µm. (M and N) CYRI
DBKO A-673 reexpressing P16-GFP-CYRI-A treated with 10 µM LY294002 show reduction in the internalized active integrin α5 signal compared the untreated
cells. (N) Quantification of at least 10 cells per experiment in a total of three independent experiments. Each experiment is color-coded. Statistical analysis
using one-way ANOVA with Tukey’s multiple comparison test. Mean ± SD. Scale bar = 10 µm. ns, P > 0.05.
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Figure 10. CYRI proteins affect the invasion ability of cancer cells through integrins. (A and B) Organotypic assay of control pLKO versus CYRI DBKO
A-673 cells stained with hematoxylin and eosin. (B) Quantification of the invasion index (the area invaded by cells divided by the total area of the plug). Data
from at least three independent experiments. Each experiment is color-coded. Mean ± SD. Statistical analysis using ANOVA with Tukey’s multiple comparison
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Macropinocytosis assay
Cells were transfected with siRNA targeting both CYRI-A and
CYRI-B genes for 48 and 24 h before seeding onto fibronectin-
coated coverslips overnight. The next day, cells were washed
three times with ice-cold PBS before being incubated with
0.2 mg/ml dextran 70 kD 488 (#D1822; Thermo Fisher Scien-
tific) for 15 or 30 min in serum-free medium at 37°C. Cells were
thenwashed five times in ice-cold PBS and fixed for 15min using
4% PFA before staining with DAPI for 30 min. 10 random fields
of view were taken using a Zeiss710 40× objective and analyzed
using a semiautomated ImageJ macro. The outline of the cell
clusters was determined by increasing the brightness with Im-
ageJ and outlining using the freehand selection tool. The back-
ground was removed. The autothreshold function MaxEntropy
in ImageJ was used to measure the internalized dextran signal.
The macropinocytic index was calculated by normalizing the
internalized dextran signal to the total area of the cell cluster for
each field of view (Commisso et al., 2014).
For overexpression experiments in Figs. 8 and 9, scramble
and DBKD COS-7 cells were transfected with either P16-mCherry-
CYRI-A WT or RRDD mutant and compared with non-
transfected scrambled and DBKD cells. Images were taken
using a Zeiss710 63× objective. Quantification was done as
described above.
Western blotting
Cells were grown to 80% confluence in a six-well plate and lysed
with radioimmunoprecipitation assay buffer (150 mM NaCl,
10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1% Triton X-100, and 0.1%
SDS) supplemented with protease and phosphatase inhibitor
cocktails (#78438, #78427; Thermo Fisher Scientific). Lysates
were spun at maximum speed for 10 min before protein levels
were measured using Precision Red (#ADV02; Cytoskeleton).
Samples were run using precast 4–12% NuPAGE Bis-Tris Ac-
rylamide Gels (#NP0321; Thermo Fisher Scientific) and trans-
ferred to a 0.45-µm nitrocellulose membrane (#10600002; GE
Healthcare). Membranes were blocked in 5% BSA in TBS + 0.1%
Tween-20 for 30 min before being incubated with specific pri-
mary antibodies overnight and the corresponding fluorescently
conjugated secondary antibody for 1 h (#A21206 and #A10038,
Invitrogen; #SA5-35521 and #SA5-35571, Thermo Fisher Scien-
tific) before being analyzed using Image Studio Lite (LiCor).
GST-Trap pulldown
For small-scale GST-tagged protein purification, BL21 competent
Escherichia coli was grown until OD 0.4 and induced with
200 µM IPTG overnight at room temperature. Cells were pel-
leted and lysed using sonication in buffer containing 50 mM
Tris, pH 7.5, 50 mM NaCl, 5 mM MgCl2, and 250 µM DTT. The
lysates were collected by ultracentrifugation at 20,000 rpm for
20 min. The lysates were added directly on glutathione se-
pharose 4B beads (#17075601; GE Healthcare) and incubated for
2 h at 4°C. If GST-tagged proteins needed to be eluted from the
beads, elution buffer containing 100 mM NaCl, 25 mM Tris, pH
8, 5 mMMgCl2, 10 mM Glutathione, and 0.1% Triton X-100 was
added and incubated overnight. At least 6 × 106 COS-7 cells on a
15-cm Petri dish were transfected with GFP-tagged constructs
overnight using Lipofectamine 2000 as described above and
lysed the next day using lysis buffer containing 100 mM NaCl,
25 mM Tris-HCl, pH 7.5, and 5 mM MgCl2 supplemented with
0.5% NP-40 and protease and phosphatase inhibitors. Lysates
were cleared by centrifugation, and 1.5 mg of protein lysate was
incubated with GST beads for 2 h before being subjected to
Western blotting as described. The signal of the pulldown was
normalized to the GFP signal.
Recombinant protein purification and SPR
In brief, BL21-competent E. coli containing MBP- or GST-tagged
protein were grown to OD 0.4 and induced overnight with
200 µM IPTG at room temperature. The next day, cells were
concentrated and lysed using the microfluidizer machine in lysis
buffer (20 mM Tris, pH 8.0, 300 mM NaCl, 5 mM MgCl2, and
2 mM β-mercaptoethanol) supplemented with protease in-
hibitors. Cell lysates were cleared using ultracentrifugation at
20,000 rpm for 45 min. The lysates were passed through an
affinity column (either MBPTrap HP, #GE28-9187-79, or GSTrap
4B, #GE28-4017-47, Sigma-Aldrich; buffer contained 20 mM
Tris, 150 mM NaCl, 5 mM MgCl2, and 2 mM DTT) before being
eluted with either 10 mM maltose or glutathione. The eluted
fractions were then subjected to size-exclusion chromatography
using an HiLoad16/600 Superdrex 200 pg. GST tags were di-
gested overnight with thrombin and separated using affinity
chromatography.
For SPR, MBP-tagged proteins were immobilized on Sensor
chip CM5 (#BR100012, GE Healthcare), and purified untagged
RAC1 Q61L was titrated at different concentrations. The re-
sponse signals were recorded and fitted into a 1:1 binding model.
The Kd was estimated from the fitted curve.
MBP-Trap pulldown assay
MBP-tagged proteins were purified from BL21 bacteria and
conjugated to MBP-Trap agarose beads (#mbta-20; ChromoTek)
similar to GST-tagged protein. 30 µl of beads were incubated
with 30 µg of purified GST-tagged RAC1 in a total of 500 µl
volume at 4°C for 90 min. The beads were washed five times
with wash buffer before being subjected to Western blotting as
described earlier. The signal of the pulldown protein was nor-
malized to the MBP signal.
test. (C and D) Inverted invasion assay comparing the invasion capacity between the control pLKO and the CYRI DBKO A-673 cells in the presence or absence of
the integrin α5β1-blocking antibody IIA1. Scale bar = 100 µm. (D) The graph shows the quantification of the invasion index (the area covered by cells beyond 10
µm into the plug). Data from at least three independent experiments. Each experiment is color-coded. Mean ± SD. Statistical analysis using two-tailed unpaired
t test. (E and F) Phase-contrast images of the soft agar assay comparing the capacity for anchorage-independent growth of the control pLKO and the CYRI
DBKO A-673 cells. The size of the spheroids is quantified in F. Scale bar = 5 cm. Data from three independent experiments. Each experiment is color-coded.
Mean ± SD. Statistical analysis using ANOVA with Tukey’s multiple comparison test. ns, P > 0.05.
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2D and 3D CDM migration assay
For the 2D random migration assay, six-well plates were
coated with 1 mg/ml of fibronectin in PBS for 2 h before
20,000 cells were seeded and left to settle for 4 h at 37°C. Cells
were imaged using a Nikon TE2000 microscope equipped
with a PlanFluor 10×/0.30 objective every 15 min for 20 h.
Individual cells were tracked manually over time using the
MTrack ImageJ plug-in, and the velocity was calculated using
Chemotaxis tool ImageJ plug-in. For IIA1 treatment, cells were
incubated with 5 µg/ml of antibody (either IgG control or IIA1)
in 1 ml of serum-free medium with rotation at room tem-
perature for 1 h. Cells were then seeded on the fibronectin-
coated surface for 4 h before being imaged with the same
Nikon system.
For the 3D CDM migration assay, CDM was generated using
telomerase-immortalized fetal foreskin (TIFF) cells. In brief,
TIFF cells were seeded on a 0.2% cross-linked gelatin-coated six-
well plate and fed with ascorbic acid every 2 d. TIFF cells were
extracted using lysis buffer containing 20 mMNH4OH and 0.5%
Triton X-100 in PBS with Ca2+ and Mg2+ for 2 min and DNase for
30min. The plates were kept in PBS at 4°C until use (Cukierman
et al., 2001). The same seeding, imaging, and analysis protocol
was used.
Wound-healing assay
A 96-well plate (#353072; Falcon) was coated with 1 mg/ml fi-
bronectin for 2 h. Cells were seeded to form a confluent mono-
layer (70,000 cells for A-673) and left to settle for 4 h. The
wound was made using the Incucyte wound maker. Cells were
stained with IncuCyte Nuclight Rapid Red reagent (#4717) for
total cells and IncuCyte Sytox Green reagent (#4633) for dead
cells. Cells were imaged every hour for 48 h using the IncuCyte
system. Analysis of wound closure was done with Zoom soft-
ware (IncuCyte Biosciences, Sartorius), where the difference in
the wound area from time 0 h to the final frame was calculated
and then divided by the length of time to get the wound closing
rate in micrometers per hour.
Proliferation assay
104 cells were seeded per well in a fibronectin-coated 96-well
plate (#353072; Falcon). Cells were stained with IncuCyte Nuc-
light Rapid Red reagent (#4717) for total cells and IncuCyte Sytox
Green reagent (#4633) for dead cells and imaged for 28 h. To
calculate the growth curve, the total number of live cells was
calculated by subtracting the number of Sytox-positive cells
from the number of Nuclight Red–positive cells. The result was
then normalized to the number of live cells from time 0. The
slope was calculated using a nonlinear regression model in
Prism7 software.
xCELLigence spreading assay
xCELLigence E-plate 16 (#05469830001; Acea) was coated with
1 mg/ml of fibronectin for 1 h. Cells were trypsinized as de-
scribed earlier and counted, and 10,000 cells were seeded on the
plate. Immediately, the plate was moved to an Acea RTCA DP
xCELLigence device, and cell spreading was measured based on
electrical impedance every 5 min for 8 h.
Live-cell superresolution fluorescence microscopy
For all live imaging experiments, cells were seeded on a 1 mg/ml
fibronectin-coated 3.5-cm dish for 4 h before imaging. During
the imaging process, cells in normal growth medium were kept
at 37°C in a 5% CO2 chamber. Imaging was performed with a
Zeiss 880 Laser ScanningMicroscopewith Airyscan with a Plan-
Apochromat 63×/1.4 oil DICM27 objective lens and deconvoluted
using Zen Black Zeiss880 deconvolution software (ZEN 2.3 SP1
FP3 v14.0.17.29).
For visualization of CYRI-A and CYRI-B, cells were imaged
every 9 s for 50 frames. The lifetime of CYRI-A on the cups/
vesicles was calculated based on the number of frames in which
the CYRI-A signal was present. For measuring the size of CYRI-
positive structures, the straight-line tool from ImageJ was used.
The largest diameter or the longest length was considered the
size of the cups/vesicles and tubules, respectively.
For measuring the lifetime of actin, the number of frames in
which the actin signal was present was counted. As many
structures as could be seen were included in the analysis.
For the actin depolymerization experiment, at least 5 cells
were imaged before Latrunculin A (#L5163; Sigma-Aldrich) or
Cytochalasin D (#C2618; Sigma-Aldrich) was added at 1 µM.
Then, at least five random cells were imaged after at least 5 min
of drug treatment. Images were taken every 9 s. Cup/vesicle
lifetime was calculated based on the number of frames in which
the structures were present.
For the PI3K inhibition experiment, nine random cells were
imaged every 30 s for 20 frames before LY294002 was added at
20 µM, and the imaging process continued for another 20
frames. The number of cups/vesicles was manually counted in
all frames for every cell. For the live-cell dextran incorporation
assay, cells were first imaged every 9 s before dextran (Texas
Red 70,000 MW Lysine Fixable, #D1864; Invitrogen) was added
at 50 µg/ml mid-imaging.
For all line graphs representing the signal intensity over
time, the signal of each channel was manually measured using
the freehand selection tool. The signals were then normalized to
the highest value and plotted over time.
To calculate the percentage of colocalization events, the
number of cups/vesicles that colocalized or did not colocalize
between two signals was counted: % colocalization events = (#
colocalizing events/# noncolocalizing events) × 100.
Flow cytometry analysis
10 × 106 cells were grown in a 15-cm Petri dish overnight. The
next day, cells were trypsinized, washed in PBS, and filtered
through a 40-µm filter. All conditions were stained with Zombie
Red reagent (#423110) before being fixed in 4% PFA for 15 min.
Cells were blocked in PBS supplemented with 1% serum for
30 min and then incubated with the corresponding primary
antibody for 15 min at room temperature. If the primary anti-
bodies were not conjugated with Alexa Fluor 488, cells were
incubated with the secondary antibody for 15 min at room
temperature before analyzing using the Attune NxT system
(Thermo Fisher Scientific). For negative control, cells were in-
cubated with anti-human mouse IgG (#400132; BioLegend). For
all conditions, dual colors of the far-red and Alexa Fluor 488 flow
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cytometry were used to minimize spectrum overlapping.
Data were imported and analyzed using FlowJo software (v.
10.6.1, BD).
qPCR
Cells were grown to 80% confluence in a six-well plate before
RNA was extracted using a standard RNA extraction protocol
according to the manufacturer (RNAeasy Mini Kit, #74104;
Qiagen). cDNA synthesis was performed by mixing 1 µg of RNA
with qScript cDNA Synthesis Kit (#95047-100; Quantabio) and
reaction conditions as follows: 5 min at 25°C, 30min at 42°C, and
5 min at 85°C using a thermocycler. qPCR was performed with
the DyNAmo HS SYBR Green qPCR kit (#F410L; Thermo Fisher
Scientific) according to the manufacturer’s protocol and was
done using the QuantStudio Real-Time PCR system. The ΔΔCt
method was used to quantify qPCR data. All primers were pur-
chased from Qiagenwebsite: Hs_ITGA5_1_SG QuantiTect Primer
Assay (#QT00080871), Hs_ITGB1_1_SGQuantiTect Primer Assay
(#QT00068124), and Hs_ACT_2_SG QuantiTect Primer Assay
(#QT01153551).
Organotypic assay
The organotypic assay was performed based on Timpson et al.
(2011). In brief, collagen was extracted from rat tails and kept in
0.5 mM acetic acid buffer at 2 mg/ml concentration. Collagen
plugs weremade bymixing TIFF cells with 25ml of collagen, and
the pH was adjusted to 7.2 using NaOH. Collagen plugs were
allowed to contract for 8 d before being transferred to a 24-well
plate. A-673 cells were prepared as usual without any trypsin
present in the final solution, and 3 × 104 were seeded directly on
top of each plug. Medium was changed every 2 d for 5 d before
the plugs were transferred onto a metal grid. A liquid–air in-
terface was set up, with the medium acting as a chemoattractant
for invasion. Medium was changed every 2 d for 14 d before the
plugs were collected and processed for hematoxylin and eosin
histology staining. Images were quantified using HALO software
(PerkinElmer). The invasion index was quantified by measuring
the invading area and normalizing it to the size of the entire
tissue section.
Inverted invasion assay
The plug was made by mixing Collagen I with Matrigel
(#354234; BD) and fibronectin (CMF) in ice-cold PBS to a final
concentration of 4, 4, and 1 mg/ml, respectively. 100 µl of the
mixture was added to each Transwell (TKT-525-110X, C3422;
Thermo Fisher Scientific) with 8-µm pore size and left to solidify
at 37°C. 5 × 104 A-673 cells were seeded on the underside of the
Transwell and left to adhere for 4 h at 37°C. The Transwell was
inverted and dipped into 500 µl of 10% serum-containing me-
dium. The top chamber was filled with 100 µl of serum-free
medium. Inhibiting antibodies were added to the top chamber
at a concentration of 5 µg/ml. The cells were left to invade for 5 d
before staining with 4 µM Calcein AM (#C1430; Invitrogen).
Z-stack images were captured every 10 µm using the Olympus
FV1000 confocal microscope with a UplanSApo 20×/0.74 ob-
jective. The invasion index was calculated bymeasuring the area
of invading cells beyond 10 µm in the plug and then normalizing
to the total area of invading cells. The area measurement was
performed using a predefined threshold function in ImageJ.
Low-attachment assay
Agarose was dissolved in PBS at 4% and autoclaved. Before the
experiments, agarose was melted in the microwave and kept in a
water bath at 65°C. To make the bottom layer, agarose solution
was mixed with 10% serum-containing medium to the final
concentration of 0.7% agarose. 1.5 ml of this was laid to make the
bottom layer. While this layer was solidifying, cells were tryp-
sinized and made into a single-cell suspension. For the top layer,
for each well, 3 × 104 cells were mixed with the agarose and
serum-containing medium to a final agarose concentration of
0.35%. 1.5 ml of this cell suspension was quickly dispensed on
top. Finally, 2.5 ml of 10% serum-containing medium was
pipetted on top. The cells were grown for 10 d, with the me-
dium changed every 2 d. Five random fields of cell spheroids
per condition were imaged with a standard bright-field mi-
croscope. Image quantification was done manually by outlining
the spheroids with the freehand selection tool in ImageJ, and the
areas of the spheroids were calculated. Only in-focus spheroids
were measured.
Cloning and primers
To make the internal GFP or mCherry CYRI-A construct, mouse
CYRI-A cDNA was cloned into the pcDNA3.1(+) vector (a kind
gift from Dr. Douglas Strathdee, Beatson Institute, Glaskow, UK)
using standard cloning techniques. HindIII and BamHI restric-
tion sites were inserted just after the codon coding for proline 16
using Q5-insertion mutagenesis (#E0554; NEB) according to the
protocol from the manufacturer. GFP or mCherry was amplified
by PCR from the pEGFP-C1 or pmCherry-N1 vector before being
inserted internally in CYRI-A.





TTCCC-39; PCR GFP or mCherry, 59-TCAACGAAGCTTGTGAGC
AAGGGCGAGGAGCTG-39, 59-TCAACGGGATCCCTTGTACAGCTC
GTCCATGCC-39, 59-TCAACGAAGCTTGTGAGCAAGGGCGAGGAG
G-39; and insert Kozak sequence, 59-GCCACCATGGGAAACTTG
CTCAAAGTCC-39, 59-GCTAGCCAGCTTGGGTCT-39. The same
strategy was used to clone for P17-GFP-CYRI-B, but the restric-
tion sites were XHoI and NheI just after the codon code for
proline 17: 59-CTCGAGGCGGCTAGCAATTTTTTCCTTGATTTT
GA-39, 59-GCTAGCCGCCTCGAGTGGCCCCTGCTCAAGGTCTG-39.




GGATCCTTATCGAATCTGTTTGGAAGTCGA-39. Primers for the
mVenus-bi-cistronic vector of CYRI-A, 59-TCAACGGCTAGCGCC
ACCATGGGAAACTTGCTCAAAGTC-39, and 59-TCAACGGGATCC
TTACTGAAGCATCGCTCGAATCTG-39. Primers for CYRI-A-FLAG,
59-TCAACGGGATCCGCCACCATGGGAAACTTGCTCAAAGTC-39
and 59-TCAACGCTCGAGTTACTTGTCGTCATCGTCTTTGTAGTC
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CTGAAGCATCGCTCGAATCTG-39. Primers for MBP-CYRI-A,
59-CGTATTGGATCCATGGGAAACTTGCTCAAAGTC-39 and 59-CGT
ATTGAAGCTTCTACTGAAGCATCGCTCGAAT-39. GFP-PH-Grp1
was a kind gift from Dr. David Bryant (Beatson Institute,
Glasgow, UK).
Addgene plasmids
mApple-α-5-Integrin-12 (plasmid #54864; RRID:Addgene_54864;
Addgene), mCherry-Clathrin LC-15 (plasmid #55019; RRID:
Addgene_55019; Addgene), and mCherry-Rab5a-7 (plasmid
#55126; RRID:Addgene_55126; Addgene) were gifts fromMichael
Davidson (Rizzo et al., 2009); pcDNA3/hArf1(WT)-mCherry
(plasmid #79419; RRID:Addgene_79419; Addgene) was a gift
from Kazuhisa Nakayama (Makyio et al., 2012); CAV1-mCherry
(plasmid #27705; RRID:Addgene_27705; Addgene) was a gift
from Ari Helenius (Hayer et al., 2010); and PH-Btk-GFP (plasmid
#51463; RRID:Addgene_51463; Addgene) was a gift from Tamas
Balla (Várnai and Balla, 1998).
Antibodies
Anti–CYRI-A antibody (rabbit, Sigma-Aldrich, not in pro-
duction; Western blotting), anti–CYRI-B antibody (rabbit,
#HPA009076, RRID:AB_1848402; Sigma-Aldrich; Western blot-
ting), anti-GAPDH (mouse, #MAB374, RRID:AB_2107445; Milli-
pore; Western blotting), anti-Tubulin DM1A (mouse, #T6199,
RRID:AB_477583; Sigma-Aldrich; Western blotting), anti-GST
(rabbit, #2622, RRID:AB_331670; CST; Western blotting), anti-
GFP (mouse, #2955, RRID:AB_1196614; CST; Western blotting),
Phalloidin 488 (#A12379; Molecular Probes), anti-Integrin β
1 antibody [12G10] (rabbit, #ab30394, RRID:AB_775726; Abcam;
immunofluorescent and Western blotting), recombinant anti-
Integrin α 5 antibody [EPR7854] (rabbit, #ab150361, RRID:
AB_2631309; Abcam; immunofluorescent and Western blotting),
anti-Integrin α5 (preservative free) antibody, clone SNAKA51
(mouse, #MABT201; Millipore; immunofluorescent, internali-
zation assay, and flow cytometry), Alexa Fluor 488 anti-human
CD29 antibody TS2/16 (mouse, #303015, RRID:AB_493026; Bi-
oLegend; flow cytometry), Alexa Fluor 488 anti-mouse CD49e
Antibody (rat, #103810, RRID:AB_528839; BioLegend; flow cy-
tometry), anti-MMP-14 antibody, catalytic domain, clone LEM-
2/63.1 (mouse, #MAB3329, RRID:AB_570600; Millipore; flow
cytometry), donkey anti-rabbit 680-nm (#A10043, AB_2534018;
Invitrogen; Western blotting), donkey anti-mouse 680-nm
(#A10038, AB_2534014; Invitrogen; Western blotting), goat
anti-mouse 800-nm (#SA5-35521, AB_2556774; Thermo Fisher
Scientific; Western blotting), and goat anti-rabbit 800-nm
(#SA5-35571, AB_2556775; Thermo Fisher Scientific; Western
blotting).
Statistical analysis
All statistical analyses were performed with Prism 7. All data
points were pooled from independent experiments or cells, and
then the appropriate statistical test was performed. Each ex-
periment is color coded. Normality was assessed by inspecting
the shape of the distribution. Parametric tests were used because
they are less affected by deviation from normal distribution and
are more robust than nonparametric tests (McDonald, 2014).
Online supplemental material
Fig. S1 shows that untagged CYRI-A could rescue CYRI-B KO
phenotype, that siRNA KD of CYRIs gave similar results as
CRISPR, and the tagging strategy of our internal CYRI construct.
Fig. S2 shows the localization of CYRI-B, the similar relation
between CYRI-A and RAB5A in HEK293T cells, that CYRI-A
positive cups/vesicles contain dextran, and that these cups/
vesicles were of similar size to cells expressing only GFP. Fig. S3
shows that both CYRI-A and CYRI-B cups/vesicles were distinct
from other canonical endocytic pathways and that CYRI-A re-
cruitment was preceded by PIP3 production and membrane
invagination. Fig. S4 shows the increase in surface expression of
integrin α5 and β1 in CYRI DBKO cells, that non-RAC1 binding
mutant CYRI-A could not rescue the spreading phenotype, and
that integrins were localized to CYRI-positive cups/vesicles. Fig.
S5 shows the working model and that the invasion of CYRI
DBKO cells could be inhibited by integrin blocking antibodies.
Video 1 shows the localization of CYRI-A in cells, its RAB5A
preceding recruitment, and the macropinocytic nature of these
cups/vesicles. Video 2 shows the the localization of CYRI-A to
macropinocytic structures prior to RAB5A recruitment. Video 3
shows the CYRI-A–positive structures are distinct from clathrin-,
caveolin-, and ARF1-mediated endocytosis. Video 4 shows CYRI-
A regulates actin dynamics at the macropinocytic structures.
Video 5 shows the knockdown of CYRI proteins affects actin
dynamics at macropinocytic structures. Video 6 shows the
effects of actin polymerization inhibition on CYRI-A recruit-
ment and lifetime. Video 7 shows the relation between CYRI-A
and RAC1 and how its recruitment to macropinocytic cups/
vesicles depends on its ability to bind active RAC1. Video 8
shows the relation between CYRI-A and PIP3 and how its
recruitment to macropinocytic cups/vesicles depends on PI3K
activity. Video 9 shows the localization of integrins on CYRI-
positive cups/vesicles.
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Figure S1. CYRI-A and CYRI-B have complementary functions in cells. (A–G) pLKO, control CRISPR line; ex3 and ex4.1, CYRI-B CRISPR COS-7 cell lines; scr,
scramble; KD3 and KD5, CYRI-A siRNA knockdowns; KD6, CYRI-B siRNA knockdown, DBKD, KD3 + KD6, or KD5 + KD6. (A) Quantification of cell area (left) and
the average Arp2/3 signal intensity around the cell perimeter in CYRI CRISPR COS-7 cells (ex3 and ex4.1) rescued with untagged bi-cistronic CYRI-A. Data from
three independent experiments; statistical analysis using unpaired t test. Each experiment is color-coded. Mean ± SD. *, P < 0.05; ****, P < 0.0001. (B)Western
blot of control or KD of CYRI-A and CYRI-B in HEK293T cells (left) and COS-7 (right) showing that HEK293T cells express only CYRI-B while COS-7 cells express
both isoforms. Tubulin and GAPDH are loading controls. (C) Western blot of endogenous CYRI-A and CYRI-B in control or KD A-673 cells. GAPDH is loading
control. (D) Representative immunofluorescence images of control scrambled (scr), single CYRI-A or CYRI-B, and CYRI-A/B DBKD in A-673 cells stained for
F-actin (phalloidin). Orange arrowheads point to C-shaped cells. Scale bar = 50 µm. (E) Quantification of the number of C-shaped cells in D. Data from three
independent experiments with at least 50 cells per experiment. One-way ANOVA with Tukey’s multiple comparisons. Mean ± SD. **, P < 0.01; ***, P < 0.001;
****, P < 0.0001. (F and G) Quantification of the mean velocity of control, single KO, and CYRI-A/B DBKD A-673 cells plated on 2D fibronectin (F) or in 3D CDM
(G). Data from at least 30 cells per experiment in a total of three independent experiments. Each experiment is color-coded. One-way ANOVA with Tukey’s
multiple comparison test. Mean ± SD. ****, P < 0.0001. (H) Schematic representation of the cloning strategy used to create the internal fluorescent tag for
CYRIs. (I) Immunofluorescence images of control or CYRI-B CRISPR COS-7 (ex4.1) transfected with either P16-GFP-CYRI-A or P17-GFP-CYRI-B (cyan) and
stained for Apr2/3 (yellow) and F-actin (magenta). Scale bar = 20 µm for full-size image or 10 µm for zoom. (J and K) Quantification of the cell area and the
average Arp2/3 signal at the cell periphery of CYRI-B CRISPR COS-7 cells (ex4.1) expressing either GFP control or the internal-GFP tagged CYRI constructs. Data
from at least 20 random fields in a total of three independent experiments. Each experiment is color-coded. One-way ANOVA with Tukey’s multiple com-
parison test. ns = P > 0.05; * P < 0.05; ****, P < 0.0001.
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Figure S2. CYRI proteins localize to macropinocytic structures prior to RAB5 arrival. (See Video 2.) (A and B) Representative images of live COS-7 cells
expressing P17-GFP-CYRI-B (scale bar = 10 µm). Tubular and vesicular structures are highlighted in zoomed panels, and quantification of their sizes is shown in
B (vesicles, n = 16 events in 3 cells; tubules, n = 22 events in 4 cells; scale bar = 5 µm). (C–E) Time sequence of live HEK293T cells (scale bar = 10 µm)
coexpressing P16-GFP-CYRI-A (cyan) and mCherry-RAB5AWT (magenta). Arrowhead points to vesicular structures (C; scale bar = 5 µm). The dynamics of each
protein is reported by its normalized intensity plot (D) and lifetime (n = 84 events in 7 cells; E). (F and G) COS-7 cells (scale bar = 10 µm) coexpressing P17-GFP-
CYRI-B (cyan) and mCherry-RAB5A WT (magenta). Time sequence corresponding to the white dotted square area is shown in the bottom panel (scale bar =
5 µm). Arrowhead points to tubular and vesicular structures, and intensity profile along the yellow line is plotted in G. (H–M) Time sequence images HEK293T
(H) and CHL-1 cells (K) expressing P16-GFP-CYRI-A and incubated with dextran 70 kD (scale bar = 10 µm). Yellow arrowheads indicate macropinocytic events
positive for both CYRI-A and dextran signals (scale bar = 5 µm). Quantification showing the majority of CYRI-A–positive vesicles are also dextran-positive in
HEK293T (I; 88%, n = 6 cells) and CHL-1 (L; 100%, n = 6 cells) and their sizes (J and M; n = 53 events in 6 cells in HEK293T; n = 57 events in 6 cells in CHL-1). Red
line indicates the average value. (N and O) HEK293T cells expressing either GFP control or P16-GFP-CYRI-A and incubated with dextran 70 kD. The size of
dextran-positive vesicles in GFP (n = 163 events in 4 cells) is the same as that of CYRI-A–positive vesicles (n = 75 events in 7 cells). Events from each cell are
color-coded. Unpaired t test. Mean ± SD.
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Figure S3. CYRI-A- colocalizes with plasma membrane-associated nascent macropinocytic structures. (See Video 3.) (A–D) Time sequence images of
COS-7 cells expressing P16-GFP-CYRI-A or P17-GFP-CYRI-B (cyan) and either mCherry-tagged CLC15 (clathrin light chain 15; A and B), Caveolin-1 (C), or ARF1
(D). Scale bar = 10 µm for full-size image and 5 µm for zooms. (E and F) Time sequence images of live COS-7 cells coexpressing either P16-mCherry-CYRI-AWT
or P16-mCherry-CYRI-A RRDDmutant (magenta) and P16-GFP-CYRI-AWT (cyan). (G–L) COS-7 cells coexpressing P16-GFP-CYRI-A (cyan) and two independent
PIP3 reporters (magenta), PH-Grp1 (G–I) or PH-Btk (J–L; n = 31 events in 3 cells for Grp1; n = 9 events in 1 cell for Btk). Red line represents the average value.
Scale bar = 10 µm for full-size image and 5 µm for zooms. (M and N) Time sequence images of HEK293T cells coexpressing P16-GFP-CYRI-A (cyan) and
mScarlet-Lck (labeling the plasma membrane; magenta). The time Lck resides on the vesicles before CYRI-A is recruited is quantified in N (n = 48 events in 10
cells). Scale bar = 10 µm for full-size image and 3 µm for zooms. Red line indicates the average value.
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Figure S4. CYRIs affect integrin α5β1 trafficking. (See Video 9.) (A and B) Flow cytometry analysis of surface expression of active integrin α5, detected
using the SNAKA51 antibody (A) and MT1MMP (B) comparing the control pLKO and CYRI-A/B DBKO A-673 cells. Data from three independent experiments.
Statistical analysis using one-way ANOVAwith Tukey’s multiple comparison test. (C–E) Immunofluorescence images of the control pLKO and DBKO A-673 cells
stained for active integrin α5 (magenta) and actin (cyan). The average area of integrin clusters or the number of clusters per cell are quantified in D and E. Data
from three independent experiments with at least 10 cells per experiment. Each experiment is color-coded. Mean ± SD. Statistical analysis use one-way ANOVA
with Tukey’s multiple comparison test. Scale bars = 20 µm. (F–H) Non-RAC1-binding mutant P16-mCherry-CYRI-A RRDD does not rescue the spreading
phenotype of CYRI-B KO COS-7. Quantification of the cell spread area (G) and the Arp2/3 signal accumulating at the cell periphery (H) show that WT CYRI-A
rescued these phenotypes in CYRI-B KO COS-7, while RRDD mutant did not. Data from at least 10 random fields of view in a total of three independent
experiments. Each experiment is color-coded. Statistical analysis using one-way ANOVA with Tukey’s multiple comparison test. Mean ± SD. ns, P > 0.05.
(I) Time sequence images of HEK293T cells coexpressing P16-GFP-CYRI-A (cyan) and mApple-integrin α5 (magenta) showing integrin α5 signal present on
CYRI-A–positive vesicles. Scale bar = 10 µm for full-sized image and 5 µm for zooms. (J–M) Immunofluorescence images of endogenous integrins α5 and β1 in
A-673 cells with the P16-GFP-CYRI-A or P17-GFP-CYRI-B constructs along with actin (yellow). Graphs show the colocalization of CYRI-A, integrins, and filamentous
actin (phalloidin) on the vesicles. Scale bars = 10 µm. In C, F, and J–M: DAPI for DNA.
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Figure S5. α5β1 integrins are important for CYRI DBKO cell invasion. (A and B) Inverted invasion assay of control pLKO and CYRI DBKO A-673 cells with
CMF plug treated with IgG (negative control), P1D6 (α5-blocking antibody), or P5D2 (β1-blocking antibody; A). The depth of invasion beyond 10 µm was
quantified as an invasion index shown in B. Data from three independent experiments. Each experiment is color-coded. Mean ± SD. Statistical analysis using
one-way ANOVAwith Tukey’s multiple comparison test. Scale bar = 100 µm. (C and D) Immunofluorescence images of control pLKO or CYRI DBKO A-673 cells
treated with 5 µg/ml of control IgG antibody or α5β1-blocking antibody IIA1 and stained for F-actin (cyan). Cell spread area was measured and plotted in D.
Data from at least 10 random fields of view per experiment in a total of three independent experiments. Each experiment is color-coded. Mean ± SD. Statistical
analysis using unpaired t test or one-way ANOVA with Tukey’s multiple comparison test where appropriate. Scale bar = 50 µm. (E) Treating DBKO A-673 cells
with α5β1-blocking antibody IIA1 shows the reduction in their migration ability on 2D fibronectin substrate. Data from at least 30 cells per experiment in a total
of three independent experiments. Each experiment is color-coded. Statistical analysis using unpaired t test or one-way ANOVA with Tukey’s multiple
comparison test where appropriate. Mean ± SD. ****, P < 0.0001. (F) The current working model: (i) RAC1, the Scar/WAVE complex, the Arp2/3 complex, and
actin drive the formation of macropinocytic cups. (ii) RAC1 activity increases lead to the recruitment of CYRI-A from a diffuse pool. (iii) CYRI-A is recruited to the
nascent macropinocytic cups or just after the cups have closed by active RAC1, where it dampens down RAC1 activity, terminates actin polymerization, and
allows for the completion of the macropinosomes, taking surface integrins into the cytoplasm. (iv) CYRI-A slowly disappears while RAB5A starts to appear.
Cancer cells lacking both CYRIs retain more integrins on their surface, which can help them adhere to the surrounding matrix to assist their migration and
invasion.
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Video 1. CYRI-A localizes to macropinocytic cup-like structures prior to RAB5A recruitment. (Four clips; related to Fig. 4.) Clip 1 (related to Fig. 4 A):
Airyscan video of HEK293T cells expressing P16-GFP-CYRI-A (cyan). Arrowheads indicate vesicles. Clip 2 (related to Fig. 4 D): Airyscan video of a COS-7 cell
expressing P16-GFP-CYRI-A (cyan). Arrowheads indicate vesicles and the diffuse CYRI-A pool. Clip 3 (related to Fig. 4 E): Airyscan video of a COS-7 cell
expressing P16-GFP-CYRI-A (cyan) and mCherry-RAB5A WT (magenta). Arrowheads indicate the vesicle. Clip 4 (related to Fig. 4 H): Airyscan video of a COS-7
cell expressing P16-GFP-CYRI-A (cyan) and dextran 70 kD (magenta). Arrowheads indicate the vesicle containing the dextran. Acquisition at 9 s/frame and
playback at 10 fps.
Video 2. CYRI proteins localize to macropinocytic structures prior to RAB5 recruitment. (Seven clips; related to Fig. S2.) Clip 1 (related to Fig. S2 A):
Airyscan video of a COS-7 cell expressing P17-GFP-CYRI-B (cyan). Clip 2 (related to Fig. S2 C): Airyscan video of a HEK293T cell expressing P16-GFP-CYRI-A
(cyan) and mCherry-RAB5A WT (magenta). Arrowheads indicate the vesicles. Clip 3 (related to Fig. S2 F): Airyscan video of a COS-7 cell expressing P17-GFP-
CYRI-B (cyan) and mCherry-RAB5AWT (magenta). Clip 4 (related to Fig. S2 H): Airyscan video of a CHL-1 cell expressing P16-GFP-CYRI-A (cyan) and dextran 70
kD (magenta). Clip 5 (related to Fig. S2 H): Airyscan video of a HEK293T cell expressing P16-GFP-CYRI-A (cyan) and dextran 70 kD (magenta). Clip 6 (related to
Fig. S2 N): Airyscan video of a HEK293T cell expressing GFP (cyan) and dextran 70 kD (magenta). Clip 7 (related to Fig. S2 N): Airyscan video of a HEK293T cell
expressing P16-GFP-CYRI-A (cyan) and dextran 70 kD (magenta). Acquisition at 9 s/frame and playback at 10 fps.
Video 3. CYRI-A is distinct from clathrin-, caveolin-, and ARF1-mediated endocytosis and colocalizes with plasma membrane–associated macro-
pinocytic structures. (Nine clips; related to Fig. S3.) Clip 1 (related to Fig. S3 A): Airyscan video of a COS-7 cell expressing P16-GFP-CYRI-A (cyan) and
mCherry-CLC15 (clathrin; magenta). Clip 2 (related to Fig. S3 B): Airyscan video of a COS-7 cell expressing P17-GFP-CYRI-A (cyan) and mCherry-CLC15 (clathrin;
magenta). Clip 3 (related to Fig. S3 C): Airyscan video of a COS-7 cell expressing P16-GFP-CYRI-A (cyan) and mCherry-Cav1 (caveolin; magenta). Clip 4 (related
to Fig. S3 D): Airyscan video of a COS-7 cell expressing P16-GFP-CYRI-A (cyan) and mCherry-ARF1 (magenta). Clip 5 (related to Fig. S3 E): Airyscan video of a
COS-7 cell expressing P16-GFP-CYRI-A WT (cyan) and P16-mCherry-CYRI-A WT (magenta). Clip 6 (related to Fig. S3 F): Airyscan video of a COS-7 cell
expressing P16-GFP-CYRI-A WT (cyan) and P16-mCherry-CYRI-A RRDD (magenta). Clip 7 (related to Fig. S3 G): Airyscan video of a COS-7 cell expressing P16-
mCherry-CYRI-A (cyan) and GFP-GRP1 (magenta). Arrowheads indicate the vesicle. Clip 8 (related to Fig. S3 J): Airyscan video of a COS-7 cell expressing P16-
mCherry-CYRI-A (cyan) and GFP-Btk1 (magenta). Arrowheads indicate the vesicle. Clip 9 (related to Fig. S3 M): Airyscan video of a HEK293T cell expressing
P16-GFP-CYRI-A (cyan) and mScarlet-Lck (magenta). Arrowheads indicate the vesicle. Acquisition at 9 s/frame and playback at 10 fps.
Video 4. CYRI-A regulates actin dynamics atmacropinocytic structures. (Four clips; related to Fig. 5.) Clip 1 (related to Fig. 5 A): Airyscan video of a COS-7
cell expressing GFP (cyan) and LifeAct-RFP (magenta). Clip 2 (related to Fig. 5 A): Airyscan video of a COS-7 cell expressing P16-GFP-CYRI-A (cyan) and LifeAct-
RFP (magenta). Arrows indicate the vesicles. Clip 3 (related to Fig. 5 B): Airyscan video of a zoom of a COS-7 cell expressing P16-GFP-CYRI-A (cyan) and LifeAct-
RFP (magenta). Clip 4 (related to Fig. 5 C): Airyscan video of a zoom of a HEK293T cell expressing P16-GFP-CYRI-A (cyan) and LifeAct-RFP (magenta). Arrows
indicate the vesicle with actin around. Acquisition at 9 s/frame and playback at 10 fps.
Video 5. Knockdown of CYRI proteins affects actin dynamics at macropinocytic structures. (Two clips; related to Fig. 5.) Clip 1 (related to Fig. 5 E):
Airyscan video of a CYRI DBKD COS-7 cell expressing GFP (cyan) and LifeAct-RFP (magenta). Clip 2 (related to Fig. 5 E): Airyscan video of a CYRI DBKD COS-7
cell expressing P16-GFP-CYRI-A (cyan) and LifeAct-RFP (magenta). Acquisition at 9 s/frame and playback at 10 fps.
Video 6. CYRI-A localization at macropinocytic cups is not abolished by latrunculin-A treatment. (Four clips; related to Fig. 5.) Clip 1 (related to Fig. 5 L):
Airyscan video of a COS-7 cell expressing P16-GFP-CYRI-A (cyan) and LifeAct-RFP (magenta) and treated with 1 µM of Latrunculin A (LatA). Acquisition at 30 s/
frame and playback at 7 fps. Clip 2 (related to Fig. 5 L): Airyscan video of HEK293T cells expressing P16-GFP-CYRI-A (cyan) and LifeAct-RFP (magenta) and
treated with 1 µM of LatA. Acquisition at 30 s/frame and playback at 7 fps. Clip 3 (related to Fig. 5 L): Airyscan video of a zoom of a COS-7 cell expressing P16-
GFP-CYRI-A (cyan) and LifeAct-RFP (magenta) and treated with 0.2 mg/ml dextran 70 kD and 1 µM of LatA. Arrows indicate CYRI-A–positive vesicles that
contain dextran. Acquisition at 30 s/frame and playback at 2 fps. Clip 4 (related to Fig. 5 L): Airyscan video of a zoom of a HEK293T cell expressing P16-GFP-
CYRI-A (cyan) and LifeAct-RFP (magenta) and treated with 0.2 mg/ml dextran 70 kD and 1 µM of LatA. Arrows indicate CYRI-A–positive vesicles that contain
dextran. Acquisition at 30 s/frame and playback at 2 fps.
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Video 7. CYRI-A recruitment coincides with and depends on active RAC1 recruitment to macropinocytic structures. (Four clips; related to Fig. 6.) Clip
1 (related to Fig. 6 A): Airyscan video of a HEK293T cell expressing P16-mCherry-CYRI-A (cyan) and GFP-RAC1WT (magenta). Arrowheads indicate the vesicles.
Clip 2 (related to Fig. 6 D): Airyscan video of a HEK293T cell expressing P16-mCherry-CYRI-A (cyan) and CFP-PBD (magenta). Arrowheas indicate the vesicle.
Clip 3 (related to Fig. 6 F): Airyscan video of a HEK293T cell expressing P16-GFP-CYRI-A WT (cyan) and P16-mCherry-CYRI-A WT (magenta). Clip 4 (related to
Fig. 6 I): Airyscan video of a HEK293T cell expressing P16-GFP-CYRI-A WT (cyan) and P16-mCherry-CYRI-A RRDD (magenta). Acquisition at 9 s/frame and
playback at 10 fps.
Video 8. CYRI-A recruitment to macropinocytic structures depends on PI3-kinase. (Four clips; related to Fig. 7.) Clip 1 (related to Fig. 7 A): Airyscan video
of a HEK293T cell expressing P16-mCherry-CYRI-A (cyan) and GFP-GRP1 (magenta). Arrowheads indicate the vesicle. Acquisition at 9 s/frame and playback at
10 fps. Clip 2 (related to Fig. 7 D): Airyscan video of a HEK293T cell expressing P16-mCherry-CYRI-A (cyan) and GFP-Btk (magenta). Arrowheads indicate the
vesicle. Acquisition at 9 s/frame and playback at 10 fps. Clip 3 (related to Fig. 7 G): Example 1 of an Airyscan video of a COS-7 cell expressing P16-mCherry-CYRI-
A (cyan) and treated with 20 µM LY294002 (as indicated). Arrowheads indicate the vesicles. Acquisition at 30 s/frame and playback at 7 fps. Clip 4 (related to
Fig. 7 G): Example 2 of an Airyscan video of a COS-7 cell expressing P16-mCherry-CYRI-A (cyan) and treated with 20 µM LY294002 (as indicated). Arrowheads
indicate the vesicles. Acquisition at 30 s/frame and playback at 7 fps.
Video 9. Integrins colocalize with CYRI-A at macropinocytic structures. (Three clips; related to Fig. 9.) Clip 1 (related to Fig. 9 A): Airyscan video of a COS-
7 cell expressing P16-GFP-CYRI-A (cyan) and mApple-ITGA5 (magenta). Arrowheads indicate the vesicles. Clip 2 (related to Fig. 9 B): Airyscan video of a COS-7
cell expressing P17-GFP-CYRI-B (cyan) and mApple-ITGA5 (magenta). Arrowheads indicate the vesicles. Clip 3 (related to Fig. S4 F): Airyscan video of a
HEK293T cell expressing P16-GFP-CYRI-A (cyan) and mApple-ITGA5 (magenta). Arrowheads indicate the vesicles. Acquisition at 9 s/frame and playback at
10 fps.
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